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1CHAPTER 1
SMALL SCALE SERVICE EVALUATION PROJECT
The Provision of Clinical Psychology Services Within a General Hospital: An 
Analysis and Interpretation of Referral Rates
Matt Wild
Department of Psychological Medicine, University of Glasgow
Prepared in accordance with guidelines for submission to 
Health Bulletin (Appendix 1.1)
2ABSTRACT
Objectives
To assess the level of knowledge and understanding, among healthcare professionals, 
about the activities of clinical psychologists and to assess perception of need for the 
clinical psychology service within a general hospital. Differences between high/regular 
and occasional/non-referring departments were examined in relation to the above 
objectives with a view towards explaining variations in referral rates to the Department 
of Clinical Psychology.
Design and Subjects
A semi-structured interview, containing items aimed at addressing the above objectives, 
was administered to fifteen hospital based medical and surgical consultants representing 
different departments.
Setting
A General Hospital in Central Scotland 
Results
High/regular referring departments displayed a greater level of knowledge and
understanding of clinical psychology practice than occasional/non-referring departments.
The occasional/non-referring departments demonstrated more cautious attitudes than
high/regular referring departments towards psychological input to the
care of patients. Overall, most departments indicated that they would be interested in
learning more about the clinical psychology service and what it could offer their
departments.
3Conclusions
The study identified a generally low level of awareness and understanding of 
psychological issues among the departmental representatives within the general hospital. 
This highlighted the need for education about the role of clinical psychology in general 
hospitals and improved communication between the psychology service and other 
departments in the hospital. The survey identified that these moves would generally be 
welcomed by departments, suggesting that lower referral rates were more likely to be a 
result of poor understanding rather than hostility or mistrust towards psychological 
methods. A larger scale study should be carried out to investigate the generality of these 
findings.
4INTRODUCTION
Clinical psychologists have the potential to contribute to the treatment of psychological 
and behavioural aspects of diseases in virtually all major medical specialities (Groth- 
Mamet, 1988). In recent years the UK has seen a significant expansion in the role of 
psychologists within general hospitals (Clifford, 1989). Despite this, clinical 
psychologists continue to be seen by other health care professions as a "virtually 
unknown group" (Osbome-Davies, 1996). Hence, a marketing task is required for the 
profession to ensure that the effectiveness of clinical psychology reaches its audiences 
(Chadd & Svanberg, 1994).
Perception of need is an important factor in referral rates, but is of particular 
consequence within the environment of general medicine and surgery. The biomedical 
model of care has predominated in these areas of medicine, potentially promoting 
passivity in the patient. This purely biomedical approach is often ineffective in treating a 
range of physical disorders, as many patients seek medical services for problems which 
are psychologically based (Schwartz, 1982). In contrast, clinical psychology aims to 
introduce more psychosocially oriented management which may conflict with traditional 
medical practice within the NHS (Broome & Llewelyn, 1995). This conflict is generally 
considered to occur through a lack of understanding of psychological practice 
(Bamgbose et al, 1980).
The attitudes and behaviours of health professionals have been observed to be influenced 
by expectations regarding health problems (McGee, 1997). A number of studies have 
reported the underdiagnosis of mental health problems in patients with physical disorders 
(Lopez, 1989). This suggests that some carers consider physical and psychological health 
problems to be distinct from each other, perhaps illustrating that those with both types of 
problem may be underserved by the current approach adopted by some health 
professionals. Perception of need has also been implicated in health outcomes. Marteau 
(1996) suggested that physician’s perceptions may impact on outcome by effecting the
5patient’s cognitions and behaviour, or by altering medical procedures and treatments as a 
result of their beliefs.
Fundamentally, there is a need to examine ways of improving psychological care within 
the setting of the general hospital. By moving away from traditional biomedical models 
of care it may be possible to establish a system which identifies and addresses the 
psychological needs of the patient. McGee (1997) suggests that further study of the 
attitudes of health professionals is necessary to counterbalance previous attention made 
to the attitudes of service users. If included in a wider research agenda, this may 
positively influence the individual professional’s understanding of their role, thereby 
improving the delivery of health services in the future.
In this study medical and surgical consultants were asked, by means of a semi- structured 
interview, about the clinical psychology service offered to departments within a general 
hospital. The Department of Clinical Psychology, the focus of this study, has offered 
psychological services to medical and surgical departments for fifteen years. The service 
is well established and referrals are regularly received from a number of departments. 
However, not all departments refer, so it was the primary aim of this study to examine 
why certain areas of medicine were not utilising the service. Further aims included;
(1) To differentiate between high/regular and occasional/non-referring departments on 
the basis of referral patterns and the decision factors involved in referral and non-referral.
(2) To assess the level of knowledge about clinical psychology and the clinical 
psychology service, among departmental representatives, and to investigate their level of 
understanding of psychological practice. It was hypothesised that high/regular referring 
departments would demonstrate a higher level of knowledge and understanding than 
low/non-referring departments.
6(3) To examine the perception of present and future need for a psychology service, as 
reported by potential referrers within the hospital. It was hypothesised that high/regular 
referring departments would report a greater perceived need for the service and would 
demonstrate a greater level of acceptance for psychological input to the care of patients.
METHODS
Participants
All nominated departmental representatives were hospital based consultants (n = 15) 
with a mean of twelve years experience at that level of practice.
Materials
A semi-structured interview (Appendix 1.2) was developed for this study and was not 
based on any standardised measurements. Items were included which related to relevant 
literature and which were felt appropriate to the aims of the study. This eighteen item 
interview included Likert type, categorical and open ended questions. These items aimed 
to examine referral patterns and processes, common perceptions about clinical 
psychology and the service it provides to medicine and surgery at present and in the 
future. The study was interview based so as to avoid the problem of low response rates 
often associated with questionnaire based surveys. The interview also gave participants 
an opportunity to offer additional information and discuss issues relating to the provision 
of the clinical psychology service in more depth.
Procedure
A letter (Appendix 1.3) was sent to the chief consultant of each medical and surgical 
department in the hospital (n = 15). This asked them to nominate a departmental 
representative to be involved in a study examining attitudes and perceptions of need 
towards the service offered by the Department of Clinical Psychology. The letter also 
stated that the representative was required to have knowledge of referral practices within
7the department. This letter was followed up by a telephone call to arrange a suitable time 
to meet with the departmental representative. All participants were met in their own 
departments and each interview took an average of twenty minutes to complete. Prior to 
administration of the interview all participants were sent the same information and 
instructions (Appendix 1.4).
All departments in the hospital, apart from the radiology department, have at some time 
referred to the service. Over recent years referrals have displayed two distinct patterns, 
that of high/regular referrers (H/R) and occasional/non-referrers (O/N). In order to 
address the aims of this study these departments were allocated to one of these two 
groups. This was conducted by examining the numbers of referrals made by all 
departments during the year prior to the present study (i.e. 1997) (Appendix 1.5). The 
median number of referrals per year was then calculated (median = 1 referral). Those 
departments above the median were placed in the high/regular referring group (H/R), and 
those below were allocated to the occasional/non-referring group (O/N). The median 
was used rather than the mean to select the groups as the range of numbers of referrals 
was large (0-31) and the mean may be skewed by these outlying variables. All those in 
the O/N group were asked question 7 (Q7; Appendix 1.2) in addition to the other items 
in the interview.
Following this process the two groups, H/R and O/N, comprised seven and eight 
participants respectively. Departments in the H/R group comprised; Infectious diseases, 
neurology, gynaecology, anaesthetics, haematology, general surgery and general 
medicine. The O/N group comprised the following departments; Radiology, accident and 
emergency, dermatology, orthopaedics, urology, cardiology, renal and ear, nose and 
throat (ENT).
8RESULTS
Referral Patterns and Processes Reported by Departments 
All representatives were aware that a psychological service was available to all 
departments within the hospital. Three departments (20%) reported that they had 
become aware of the service because they had specifically looked for it, the remainder 
(80%) could not recall how they became aware of the service. Half of the O/N group 
said that they would not refer to the department. The remaining four departments in that 
group reported they would refer 1-5 patients to the service each year. In the H/R group 
28.6% identified 16-20 as their most representative referral rate. The same number of 
representatives identified 6-10, and the remaining 42.8% opted for 1-5. Of those in the 
O/N group that said they referred, none believed that they were making full use of the 
service. Reasons for this included an awareness of limited resources in the clinical 
psychology service and a lack of psychological understanding among colleagues (e.g. 
one consultant said, "If they can’t operate, they don’t want to know"). In the H/R group 
three of the seven representatives reported that their perception of a long waiting list 
prevented them from making full use of the service.
Question 7 was only administered to participants in the O/N group. Results from this 
item indicated that all eight participants identified, as reasons for non-referral, a lack of 
information about the service and about the role of clinical psychologists within the 
hospital. A quarter of the departments did not consider the service to be relevant to the 
care of medical and surgical patients, but all of those asked believed that clinical 
psychologists did have a role to play in the hospital. All occasional referring departments 
(n = 4) perceived the waiting list to be too long and six departments felt that they might 
consider referral to another agency before referring to clinical psychology. These other 
agencies most commonly included psychiatry or the patient’s GP.
Table 1 shows that all participants in the O/N group considered "waiting times for 
treatment" and a "good outcome from previous referral" to be important in their decision
9to refer to the service. There was a significant difference between the responses of the 
O/N group and the responses of the H/R group (waiting list, %2(1)=4.29, p < o.05; good 
outcome, %^(1)=4.29, p < 0.05). Both groups identified the patient’s motivation to seek 
psychological support as important in their decision making process. The H/R group (n =
7) also believed that knowledge of a member from staff at the Department of Clinical 
Psychology was important.
Insert Table 1 here
Level o f Knowledge and Understanding about Clinical Psychology Practice as 
Demonstrated by Departments
Respondents from both groups suggested that treatment of anxiety, depression, 
psychosexual difficulties and adjustment to life events were services offered by clinical 
psychologists (Appendix 1.6). Table 2 shows that the H/R group identified behavioural 
management as a service offered by clinical psychologists significantly more often than 
the O/N group (%^(1) = 4.77, p < 0.05). All participants in the H/R group recognised 
that relaxation training was also offered by the service. Hypnotherapy and advice about 
medication (included as distracters) did not differentiate between the groups.
Insert Table 2 here
It can be seen in Table 3 that participants in the H/R group rated pain management and 
psychological preparation for physical treatment as significantly more relevant to their 
department than did the O/N group (pain, Mann-Whitney U = 6.0, p < 0.05; 
psychological preparation, U = 6.5, p < 0.05). Overall, behavioural management, 
adjustment to life events, neuropsychological assessment and relaxation techniques were 
rated highly relevant by the H/R group. A similar pattern was observed in the O/N 
group, although relevance ratings provided by these representatives were deflated.
Insert Table 3 here
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Overall, both groups most commonly identified adjustment to life events (n = 11), 
behavioural management (n = 13), neuropsychological assessment (n = 10) and 
relaxation techniques (n = 13) as services offered by the Department of Clinical 
Psychology. They also consistently rated these services as highly relevant to their 
departments (adjustment, mean = 7.45, SD = 1.86; behavioural management, mean = 
6.45, SD = 2.7; neuropsychological assessment, mean = 6.4, SD = 2.5; relaxation, mean 
= 7, SD = 2.2). The H/R group overall rated all services as significantly more relevant 
than did the O/N group (U = 39, p < 0.01). The overall mean relevance ratings for the 
H/R and O/N groups were 7.2 and 4.9 respectively. So, the H/R group identified more 
services provided by the Department of Clinical Psychology and rated them as more 
highly relevant to the care of patients in their departments than did the O/N group 
(Appendix 1.7).
Most participants in the H/R group (71.4%) reported that they would like to wait no 
longer than one month for a clinical psychologist to contact their patient following a 
routine referral. The remaining two (26.8%) participants were prepared to wait up to 
three months. For an urgent referral, most (71.4%) would not wait for more than one 
week. The remaining departments (n=2) would accept a wait of no more than one day. 
In the O/N group most (75%) would wait for up to one month following a routine 
referral. Two departments (25%) would accept a waiting list of up to three months. In 
terms of an urgent referral, three participants (37.5%) would like contact with a clinical 
psychologist within one day, and five (62.5%) would be prepared to wait for up to one 
week.
Perception o f Need for a Psychological Service as Reported by Departments 
The H/R group currently perceive the service as significantly more important to the care 
of their patients than the O/N group (U = 9.5, p < 0.05). In general most participants in 
the O/N group (75%) did not feel that they currently had enough information about the 
service, while most members of the H/R group (71.4%) felt that they did have enough
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information. Despite this, only one participant from the H/R group felt that they did not 
need further information about what the clinical psychology service could offer their 
department. Sixty three percent of the O/N group and 85.7% of the H/R group reported 
that they would be interested in occasional talks by a clinical psychologist within their 
department.
All participants in the H/R group believed that clinical psychology had a future role to 
play in the care of patients in their departments. Six out of the eight participants in the 
O/N group believed that there was a future role. Similar patterns were observed in the 
responses of participants to questions about the types of future psychological 
involvement. Every consultant stated that one-to-one contact was possible within the 
hospital. Fifty percent of the O/N group felt that ward, consultancy, group and support 
work would be beneficial to their patients. In the H/R group 85.7% thought that ward 
and consultancy involvement would be beneficial and 57.1% felt that group and support 
work could benefit their department (Appendix 1.8).
DISCUSSION
The results of this study are now discussed in terms of the study aims.
Referral Patterns and Processes Reported by Departments
Although all departments were aware that the service existed, few could recall how they 
became aware of it. This suggests a lack of effective "marketing" by the Department of 
Clinical Psychology. The low level of perceived use of the service also supports this 
observation. Many departments reported that a long waiting list prevented them from 
referring. There was no formal item in the interview which questioned the perceived 
length of waiting list, but when asked informally how long they thought the waiting list 
to be, a number of participants thought it was more than one year and all believed it to be 
more than six months for all referrals. In practice, the waiting list is usually less than four
12
months, with most urgent referrals being seen within two days. Some years ago the 
waiting list was long due to staff shortages, but the length of the current waiting list has 
obviously not been communicated to those who found it to be a problem in the past.
Long waiting lists were identified by non-users as a barrier to referrals. A lack of 
information and understanding about the role of clinical psychologists was also identified 
as a reason for non-referral. However, very few departments believe clinical 
psychologists have no beneficial input to offer. This lack of understanding is perhaps 
reflected by the fact that non-referrers believe that a "good outcome from a previous 
referral" is so important in their decision to refer. Such views suggest that these 
departments are sceptical of clinical psychology and that its utility remains to be shown. 
Among the referring group a greater understanding of clinical psychology was 
demonstrated, as all participants identified the importance of "knowledge of a member of 
staff at the Department of Clinical Psychology". It is recognised that these participants 
believe that good communication is vital if they are to gain satisfactory input to 
appropriate referrals.
Level o f Knowledge and Understanding about Clinical Psychology Practice as 
Demonstrated by Departments
The overall impression of clinical psychology within the hospital appears to reflect rather 
traditional attitudes towards psychological practice. In response to an open question 
about the work of psychologists, most participants communicated that it included the 
treatment of depression, anxiety, stress reactions and psychosexual problems. However, 
when comparing referring and non-referring groups, referring departments were aware of 
more recent advances in psychological input (i.e. pain management, psychological 
preparation for physical treatment) and were more likely to perceive these to be 
important in the care of their patients.
Desired maximum waiting times for treatment were generally higher than could be 
provided by the service. However, there was little difference between referrers and non-
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referrers in terms of these preferred times. This would suggest that even though referring 
departments would like to see shorter waiting times they are still prepared to refer even 
with the current length of the waiting list. However, it could also mean that these 
departments are aware of the time pressures on clinical psychology department and 
consequently only refer priority cases. Non-referring departments, as mentioned 
previously, lack knowledge about the true length of the waiting list believing it to be, in 
some cases, more than one year. This further highlights the need for greater 
communication and information sharing between the Department of Clinical Psychology 
and other departments within the hospital.
Perception o f Need for a Psychological Service as Reported by Departments 
Not surprisingly, referring departments perceive a greater need for psychological input 
than non-referring departments. This seems to be closely related to the level of 
knowledge about psychological services held by members of these departments. Despite 
the high levels of understanding among referring departments most were still keen to 
hear more about further input which clinical psychology may be able to offer within their 
departments. This seems to reflect a more open attitude and greater interest in 
psychological issues.
The majority of departments were open to the possibility of involving psychologists in 
the care of their patients. Non-referring departments again displayed a more guarded, 
traditional view of how that input might occur. Such departments tended to be less keen 
to use clinical psychologists on the ward and were less interested in consultancy.
Assessment o f Reasons For Referral/Non-Referral
Overall, the main reason for non-referral seems to be a lack of understanding about the 
role of clinical psychologists in hospital settings. This is compounded by very traditional 
views about clinical psychology and psychological issues in healthcare. Lack of 
knowledge about the clinical psychology service in general (i.e. waiting list times, 
psychological services relevant to particular departments) seems to be another salient
14
reason for not referring. This is exacerbated by poor communication and information 
sharing between such departments and the Department of Clinical Psychology.
In contrast, reasons for referral are in general the opposite of those mentioned above. 
Referring departments display a detailed knowledge of the psychological services they 
require, a very open attitude towards psychological issues in medicine and surgery and 
also a willingness to communicate directly with the Department of Clinical Psychology.
LIMITATIONS
The small sample of participants in this study limits the generality of the findings. A 
larger sample would have been desirable, but was not possible due to time constraints. 
Possible differences between the referring and non-referring groups may have been 
masked by extraneous variables. Furthermore, it would be unrealistic to suggest that the 
views of one consultant were a representative reflection of an entire department. The 
nature of the sample selection has probably yielded participants with more positive views 
of clinical psychology within their department. This has been taken into consideration in 
the interpretation of results. In short, a larger scale study may have revealed more 
striking results.
The design of the questionnaire was such that participants found some items difficult to 
respond to with certainty. For example, when asked abut their views on clinical 
psychology within medicine and surgery (i.e. Q11), they found it difficult to generalise 
their views outwith their own department. This may have skewed results, whereby 
participants identified services they thought may be beneficial to their own department 
rather than to medicine in general. Nevertheless, the questionnaire adequately covered 
the issues pertinent to service provision.
15
IMPLICATIONS
These results support previous research which reported that the work of clinical 
psychologists is not clearly understood by some health care professionals (Osbome- 
Davies, 1996). Clinical psychologists need to educate these professions in order to 
further develop psychological services (Chadd & Svanberg, 1994). Some of the less 
positive views of psychology result from a lack of understanding about psychological 
practices (Bamgbose et al, 1980) and the tendency for some healthcare professionals to 
adhere strictly to the biomedical model of treatment (Broome & Llewelyn, 1995).
This study gives rise to a number of recommendations for the provision of psychological 
services to general hospitals. Firstly, education is vital to ensure that medical and surgical 
departments are made aware of relevant psychological services. Secondly, continued 
communication is vital. Attracting referrals from departments will be pointless if these 
referrals are inappropriate and are not based on a good understanding of psychological 
practices. Finally, a lack of understanding of the psychological service was demonstrated 
by a number of departments, but in most cases these representatives were keen to learn 
more about the service. It seems that their low referral rates relate more to this lack of 
knowledge rather than to antipathy towards clinical psychology in general.
CONCLUSION
Clinical psychologists and doctors alike can learn from the findings of this study. There is 
a growing awareness within the medical profession that psychological input can greatly 
benefit some groups of patients within general hospital settings. In general though, the 
level of understanding and knowledge of these psychological practices is still rather low. 
It is the task of clinical psychologists who work in these settings to appropriately market 
their services, to educate potential referring agents and to promote good communication 
with these departments. This study has shown that the majority of those interviewed
16
would support such steps. Through this, those who subscribe to the biomedical and 
psychosocial models of healthcare may further their appreciation of the strengths and 
weaknesses of their own approach to treatment. As a result they may find more common 
ground, thereby improving the level of psychological care within the setting of the 
general hospital.
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CHAPTER 2
MAJOR RESEARCH PROJECT LITERATURE REVIEW
A Psychosocial Approach to the Understanding of Compliance with Continuous 
Positive Airway Pressure Therapy for Obstructive Sleep Apnoea Syndrome
Matt Wild
Department of Psychological Medicine, University of Glasgow
Prepared in accordance with guidelines for submission to 
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SUMMARY
Obstructive sleep apnoea syndrome is a disorder of neural respiratory and upper airway 
function which results in repeated partial and complete occlusion of the upper airway 
during sleep. Symptoms primarily include excessive daytime sleepiness, cognitive 
difficulties and changes in mood, although this condition has also been associated with 
mortality through motor vehicle accidents and cardiovascular disease. The treatment of 
choice is continuous positive airway pressure. This is a highly effective treatment, 
however its efficacy depends on compliant use above a clinically specified number of 
hours per night. In the obstructive sleep apnoea population compliance rates have 
typically been found to be low, raising concerns about the long-term health of sufferers. 
So far, research has failed to conclusively explain low compliance rates on the basis of 
physical and clinical variables relating to obstructive sleep apnoea syndrome and 
continuous positive airway pressure treatment. In this review, a psychosocial approach 
to the understanding of compliance behaviour in this population is proposed. Social 
cognition models, which advocate that cognitive variables (i.e. beliefs held by an 
individual) are the primary determinant of social behaviour, have been successfully 
applied to other areas of health-care. There, they have helped to identify those who are 
likely to comply with certain forms of treatment. It is suggested that a psychosocial 
approach to the understanding of continuous positive airway pressure compliance rates 
may help to explain further variance in this behaviour.
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The Nature of Obstructive Sleep Apnoea
Obstructive sleep apnoea (OSA) is a disorder of neural respiratory and upper airway 
function resulting in repeated partial and complete occlusion of the upper airway during 
sleep (Orr, 1997). This occlusion leads to numerous arousals from sleep (accompanied 
by loud snoring and gasping) throughout the night. Such apnoeic events are associated 
with reduced oxyhaemoglobin levels (Kribbs, 1997) and in turn lead to excessive 
daytime sleepiness (Reeves-Hoche, 1994), deterioration in cognitive performance 
(Greenberg et al, 1987; Findley et al, 1986) and changes in mood, such as increased 
irritability and depression (Engleman et a l , 1993). Induced daytime sleepiness is also 
thought to be associated with mortality through motor vehicle accidents (Young et al, 
1993) and chronic cardiovascular disease (Douglas & Polo, 1994). However, the causal 
link between OSA and poor health outcomes has been disputed in a review of the health 
effects of OSA by Wright et al (1997). It was argued that OSA is closely associated 
with obesity (Levinson, 1993) and old age (Ancoli-Israel, 1994) and that sleep apnoea 
may simply be a marker, or a symptom of obesity or old age rather than a separate 
disease entity. However, the systematic review did find more convincing evidence for a 
causal association between OSA, daytime sleepiness and vehicle accidents. Therefore, it 
may be that as Kryger (1994) suggests, OSA is not a disease itself, but a final common 
pathway of many diseases.
Treatment Options for OSA
Weight Reduction
A variety of options are available for the treatment of OSA. The majority of patients 
with OSA are overweight and weight loss has been shown to be effective in improving 
associated symptoms (Browman et al, 1984). However, weight reduction is a complex 
process and is notoriously difficult to manage in patients with morbid obesity. 
Eliminating pharmacological elements which are known to suppress respiratory
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function (i.e. alcohol, sedative medications) may also be an option, although this 
method is generally used as an adjunct to other interventions (Saskin, 1997).
Pharmacological Intervention
Pharmacological treatments have also been employed. Respiratory stimulant medication 
of the kind used in the management of asthma has not shown any systematic benefit in 
the treatment of OSA (Espinoza, 1987). There were a number of studies published in 
the early 1980s which reported that L-tryptophan (an essential amino acid involved in 
the regulation of the neurotransmitter serotonin) reduced the frequency of apnoeic 
episodes in patients with mild sleep apnoea (Schmidt, 1985). L-tryptophan though was 
linked with the development of eosinophilia-myalgia syndrome (a disorder 
characterised by symmetric and painful inflammation, and loss of elasticity in the 
tissues of the hands, arms, legs and feet) and the risk associated with its use was felt to 
outweigh the therapeutic advantages (Hertzman et al, 1990).
Dental Prosthesis
Dental appliances designed to advance the lower jaw, thereby increasing the posterior 
airway space, have been associated with improved treatment success (Fleetham, 1996), 
but large randomised clinical trials are still required to further determine the precise 
indications, benefits and risks of using oral appliances in the treatment of OSA.
Surgery
Surgery is also possible to achieve maxillomandibular advancement (Riley et al, 1986). 
Other surgical procedures such as tracheostomy and more advanced techniques such as 
uvulopalatopharyngoplasty have shown good success rates. However, the cost, 
complexity and not least the lack of acceptance of these aggressive procedures by many 
patients has prevented their widespread application (Saskin, 1997).
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Continuous Positive Airway Pressure Therapy
The final treatment option is nasal continuous positive airway pressure (CPAP). This 
was developed by Sullivan et al in 1981 and has become widely accepted as the most 
effective choice of therapy in the treatment of OSA (American Thoracic Society, 1994; 
Douglas, 1998). CPAP works by forcing the airway to remain open with a constant 
stream of room air blown through the nose during sleep via a mask or nasal prongs. The 
efficacy of CPAP is not entirely unrefuted however. In their review of the literature 
examining the efficacy of CPAP in the treatment of OSA, Wright et al (1997) made a 
number of methodological criticisms of the research completed in this area. They 
concluded that the studies did not provide enough robust evidence to support the 
efficacy of CPAP and that well designed, large scale, randomised controlled trials 
should be conducted to objectively assess its efficacy and cost effectiveness. Another 
review (Australian Health Technology Advisory Committee, 1996) arrived at a more 
positive conclusion, suggesting that CPAP was effective in patients who displayed more 
than 20 apnoeas (i.e. temporary cessations of breathing) and hypopnoeas (i.e. periods 
during which there is a decrease in the amount of air breathed) per hour of sleep plus 
daytime sleepiness. Douglas (1998) also concluded positively that there is strong 
evidence for the efficacy of this therapy. As evidence, five articles were cited, including 
three as yet unreviewed articles (Engleman et al, 1997a; Engleman et al, 1997b; Badia 
et al, 1997; Engleman et al, 1998; Stradling et al, 1998). These five controlled studies 
all showed consistent improvements in symptoms and daytime function with CPAP in 
patients with OSA. Added to this it was suggested that Wright et al’s review harboured 
an undisclosed conflict of interest as it was funded in part by purchasing authorities 
concerned about the increasing costs of sleep services and CPAP. In addition, none of 
the authors had clinical experience of sleep apnoea. Therefore CPAP is still considered 
by many to be the treatment of choice for OSA.
Treatment Compliance Issues in CPAP Therapy
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Symptom reduction is dependent on, usually lifelong, nightly use of the CPAP 
apparatus, for approximately three hours or more (Engleman et al, 1996), as symptoms 
return almost immediately after one night without treatment (Kribbs et al, 1993). 
However, despite its success in relieving symptoms it has been demonstrated that 
compliance with this treatment often falls below that which is clinically effective 
(Waldhom et al, 1990; Rauscher et al, 1991). Early studies relied on self-reported 
patient data to examine compliance rates. However, such methods were found to be 
substantially unreliable (Engleman et al, 1996). Covert time counters (activated when 
the unit is running) have been introduced to CPAP apparatus and have enabled more 
accurate objective measurement of compliance rates. CPAP compliance rates, utilising 
this method of measurement, have been reported to be as low as 50% (American 
Thoracic Society, 1994). This is of major concern, not only because of service cost 
implications, but because of the previously discussed long and short term risks to health 
associated with untreated OSA.
Predictors o f Low Compliance Rates in CPAP Therapy
It could be suggested that the low compliance rate is not surprising, considering that 
CPAP is a self-administered, demanding treatment with associated constraints (e.g. 
being attached to the apparatus, noise, claustrophobia) and possible side effects (e.g. 
nosebleeds, dry throat, skin irritation from mask). A large body of research exists on the 
issue of compliance with CPAP. This has examined some the drawbacks of CPAP 
treatment, such as those mentioned above, in an attempt to explain the generally low 
compliance rates associated with the therapy. Collard et al (1997) reviewed this 
literature and stated that the research examining the determinants of primary acceptance 
and compliance to CPAP is contradictory. Wide variation in methodology and analysis 
is demonstrated in this literature. Studies have investigated the link between physical 
variables relating to OSA and CPAP therapy compliance rates, both as a primary 
research objective and also as part of a wider hypothesis regarding CPAP therapy. The
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research can certainly explain some, but not all of the variance in compliant behaviour. 
These points can be demonstrated by summarising a small selection of the more recent 
relevant research (see Table 1). CPAP use has been predicted by polysomnographic 
severity in some studies (Rauscher et al, 1991; Meurice et al, 1994) but not others 
(Hoffstein, 1992; Reeves-Hoche, 1994), by sleepiness in some (Rauscher et al, 1991; 
McArdle et al, 1999) and not in others (Engleman et al, 1994; Kribbs et al, 1993), and 
by CPAP treatment side effects in some (Hoffstein et al, 1992; Rauscher at al, 1993) 
but not by others (Fletcher & Luckett, 1991; Pepin et al, 1995). Research has not been 
able to conclusively explain low compliance rates on the basis of clinical or physical 
variables.
Psychosocial Approaches to the Study of Health Behaviours
Before continuing to discuss additional perspectives on the problem of non-compliance 
in CPAP therapy, it is important to define the term compliance. Haynes (1979) defined 
compliance as, the extent to which a patient’s behaviour coincides with medical advice. 
This definition reflects the biomedical model of health-care. In this model the doctor- 
patient relationship is based on the fact that the health-care professional holds 
legitimate, expert and informational power over the patient (Marteau, 1995). This 
approach focuses on the biological basis of pathology and largely ignores the 
psychological and social aspects of illness. The psychosocial model represents a 
different approach to health-care. This model recognises the impact that psychological 
and social factors can have on the course of an illness. The psychosocial model sees 
compliance as a complex, or series of behaviours (Ley, 1997), rather than simply a 
behaviour which may, or may not reflect medical advice. Further to this, Conner & 
Norman (1996b) included compliance within their definition of health behaviour. They 
defined health behaviour as any activity undertaken for the improvement of well-being.
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So far, the research examining compliance rates in CPAP therapy has been driven by 
the biomedical model and has therefore focused on clinical and physical variables as 
possible determinants of eventual compliance. As yet, little attention has been paid to 
the psychological and social factors which may play a part in reduced rates of 
compliance in CPAP therapy. However, one study examined patients’ pre-treatment 
psychological status to investigate whether psychological measures could contribute to 
the prediction of CPAP compliance (Edinger et al, 1994). In this study the Minnesota 
Multiphasic Personality Inventory (MMPI) was administered to 38 patients with OSA 
prior to being placed on CPAP therapy. The subjects were followed up six months later 
to assess their level of CPAP use and were labelled as either "compliers" or "non- 
compliers". Regression analysis showed that MMPI hypochondriasis and depression 
scales along with Body Mass Index and ratings of sleep quality and daytime sleepiness 
significantly contributed to the prediction of compliance (R2 = 0.63). It was concluded 
that personality measures and subjective measures may be useful in predicting long 
term CPAP use.
The pre-treatment psychological status of OSA sufferers has not been further 
investigated directly. However, another study (Hoy et al, 1999) took psychosocial 
variables into account when trying to improve patient compliance. This study postulated 
that an intensive educational programme combined with increased nursing support 
might help to improve patient compliance. It was also hypothesised that CPAP use 
would be greater in those patients who initiated their own referral than those asked to 
seek help by a partner. Eighty patients took part in this prospective, randomised, 
controlled, parallel group trial of standard support versus intensive support for new 
OSA patients beginning CPAP therapy. In addition to finding that intensive support did 
increase compliance rates it was also demonstrated that CPAP use was greater in those 
who initiated their own referral (p = 0.002). These patients had similar baseline 
symptoms, sleepiness scores and apnoea/hypopnoea frequencies to the patients who 
were prompted by a partner to seek help. Therefore, differences in disease severity 
cannot explain the differences found in CPAP usage between these two groups. In
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addition to this, CPAP use did not decline over time in the self-referring patients, but 
did decline in the partner referred group. This result was not interpreted from a 
psychological perspective, but provides further evidence to support the suggestion that 
pre-treatment psychological factors may play a role in determining eventual long-term 
compliance with CPAP therapy.
Compliance Issues in Other Chronic Disease
Low rates of compliance are not peculiar to CPAP therapy. Poor compliance with 
management advice has been reported in many other chronic diseases (Epstein & Cluss, 
1982) such as diabetes mellitus (Shillitoe, 1995) which requires similar amounts of 
patient involvement, lifestyle change and commitment, to that of CPAP. Again, a body 
of biomedically based compliance literature exists, however, psychosocial factors (e.g. 
self-efficacy, locus of control, social support networks) have also been widely 
investigated in an attempt to explain the variability of compliance rates in diabetes 
mellitus (Kavanagh et al, 1993; Tillotson & Smith, 1996).
Psychosocially based theories, such as social cognition models have played a central 
role in the study of health behaviours in chronic disease. Their application will now be 
discussed further.
The Application of Social Cognition Models to the Study of Health Behaviours
Much of this research has focused on examining the cognitive factors which may 
determine the practice of a health behaviour such as complying with medical advice. A 
variety of models exist which hypothesise how these cognitive factors can produce 
health behaviours. These are collectively known as social cognition models. Social 
cognition models provide a framework for understanding the determinants of
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behaviour. They advocate that cognitive variables are the primary determinant of 
individual social behaviour and most assume that these behaviours and decisions are 
based on elaborate, but subjective, cost/benefit analysis of the most likely outcome of 
differing courses of action (Conner & Norman, 1998). It is recognised that these models 
have made a valuable contribution to the understanding of who will reliably perform 
health behaviours (Marteau, 1995). So, as social cognition models have helped to 
further the understanding of compliance issues in other chronic diseases, it follows that 
similar models may be of benefit in the study of variability in compliance with CPAP 
treatment for those who suffer from OSA.
Health Locus o f Control and Health Value
One such model, the health locus of control, has been heavily researched in the 
prediction of health behaviours. This construct has developed from Rotter’s (1954) 
social learning theory, which states that the likelihood of a behaviour occurring in a 
given situation is a function of the individual’s expectancy that the behaviour will lead 
to a specific reinforcement and the extent to which that reinforcement is valued. 
However, expectancies are not always situation specific, as individuals develop 
generalised expectancies through a variety of learning experiences. These generalised 
expectancies cut across situations. Locus of control is one generalised expectancy in 
Rotter’s social learning theory and refers to an individual’s beliefs about whether control 
over valued reinforcements is internal or external to that individual.
The mixed results gained from early research using Rotter’s (1966) Internal -External 
scale to predict health behaviour led to criticisms that the Internal-External scale was 
too generalised and that the locus of control construct may not be unidimensional 
(Conner & Norman, 1998). Levenson (1974) suggested that internal (i.e. own actions) 
and external (i.e. environmental factors) locus of control beliefs may be orthogonal and 
that within external locus of control a distinction should be made between external 
control exerted by powerful others (i.e. health professionals) and the influence of 
chance (i.e. fate). This led to the development of the multiple health locus of control
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scale (Wallston, 1978). Importantly, according to social learning theory, perception of 
control over health should only be predictive of health behaviours in those who value 
their health, as behaviours are dependent on both expectancy beliefs (i.e. health locus of 
control) and the value attached to certain outcomes (i.e. health value). So, according to 
this theory, in the case of insulin dependent diabetes mellitus, compliant health 
behaviour (i.e. carrying out the blood sugar level monitoring and insulin administration 
regime suggested by health professionals, so as to achieve effective glycaemic control) 
should be observed and predicted in those who place high value on health locus of 
control beliefs (e.g. effective glycaemic control is ultimately determined by the 
individual who has diabetes, rather than by the health professional) and health value 
beliefs (e.g. it is important to develop good glycaemic control so that further diabetes 
related symptoms can be prevented).
The overall variance in health behaviour explained by the health locus of control 
construct is rather low, even when combined with health value (Norman & Bennett, 
1996). However, the general pattern of results has been in line with predictions that 
health locus of control and health value combine to predict health behaviour.
Self-Efficacy
In contrast, self-efficacy has proven to be one of the most powerful and consistent 
predictors of health behaviour (Wallston, 1992). This has its origins in Bandura’s 
(1977) social cognitive theory, which posits that behaviour is a function of incentives 
and expectancies. Three types of expectancies have been identified. Situation-outcome 
expectancies which relate to beliefs about how events are linked, outcome expectancies 
which relate to the consequences of performing a behaviour, and self-efficacy 
expectancies which relate to beliefs about an individuals ability to perform the 
behaviour. Self-efficacy expectancies, or perceived self-efficacy, refers to an 
individual’s belief in their capability to organise and carry out the courses of action 
required to deal with prospective situations. These self-efficacy expectancies are 
believed to be the most important component in the eventual execution of a health
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behaviour (Bandura, 1991) and the self-efficacy construct has successfully been used in 
the prediction of a number of health behaviours, such as AIDS risk-reducing behaviours 
and smoking cessation (Schwarzer & Fuchs, 1996). However, the amount of explained 
behavioural variance has still remained rather low.
Wallston ’s Modified Social Learning Theory
Wallston (1992) modified Rotter’s (1954) social learning theory in an attempt to explain 
health behaviour as a function of health locus of control, health value and self-efficacy. 
Self-efficacy was substituted for locus of control as the major generalised expectancy 
construct. In this modification, locus of control is considered to be a moderator 
variable. So, assuming that health is a valued reinforcer, intemality (locus of control) 
and self-efficacy interact to predict health behaviour (see Figure 1). Internal health 
locus of control beliefs are therefore necessary, but not sufficient, to perform a health 
behaviour.
As yet this theory has not been applied to a clinical population, but considering the 
combined success of the constructs involved it may be a logical starting point for the 
application of cognitive approaches to the understanding of compliant behaviour in 
CPAP users. In the case of CPAP use, in line with Wallston’s model, eventual long term 
CPAP users would be expected to display generally high levels of health locus of 
control, health value and self-efficacy.
Limitations of Social Cognition Models
Despite the successful application of social cognition models to a variety of health 
related fields this approach has received considerable criticism. The main themes of 
such criticism will now be reviewed.
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Criticism has been made of psychological research which has aimed to investigate and 
measure cognitions. Issues have been raised as to whether such hidden processes can be 
accurately self-reported (Nisbett & Wilson, 1977). Added to this the relationship 
between cognitions and behaviour has been questioned. Cognitive models of behaviour 
assume that cognitions determine behaviour, but this relationship may not be directly 
causal and may be influenced by other processes or influences (Weinman et al, 1995). 
Again, in relation to this, social cognition models focus explicitly on cognitive 
variables, perhaps to the exclusion of other variables (i.e. emotional, environmental) 
potentially important in predicting health behaviour (Cartwright, 1979).
Practical issues regarding measurement have also been raised. A variety of measures 
have been used to investigate the same construct, creating difficulties in cross-study 
comparison and evaluation of that construct. Studies have also been criticised for 
paying too little attention to the reliability and validity of these measures (Marteau, 
1995). In some cases cognitive theories have been incorrectly conceptualised by 
researchers and when data has been collated in accordance with theory it has not then 
been analysed in line with the theoretical predictions. The issue of specificity in 
measurement must also be mentioned. Criticisms have been made of studies which have 
used generalised instead of disease specific measures to investigate health related 
cognitive processes. However, more specific cognitive variables are not always better, 
as Winett (1985) suggested that a strict specific focus may lead to the detachment of the 
individual from broader environmental influences. The appropriate level of specificity 
must be considered and selected carefully on a study by study basis.
If social cognition theory were to be applied to the issue of compliance with CPAP 
therapy, the above criticisms would have to be considered. The adoption of a clear, 
theoretically based model and the employment of well established generalised measures 
to assess the major implicated constructs would go some way towards addressing such 
difficulties.
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Advantages of Social Cognition Models
It remains that there are many advantages to using social cognition models (Confer & 
Norman, 1998). They provide a clear theoretical background on which to base future 
research. They also provide a basis for the selection and development of reliable, valid 
measures and an understanding of how they interact to predict health behaviours. In that 
these models identify variables important in the prediction of health behaviours, they 
also help to specify possible interventions (e.g. to increase compliance). Such 
approaches also add to our understanding of the cognitive processes involved in the 
motivation to perform health behaviours.
It is clear that social cognition models have identified important determinants of health 
behaviour and that continued interest in these models is justified. However, the 
application of these approaches to varying areas of health care, coupled with the 
continued development and refinement of such models is to be encouraged and may 
lead to better prediction of behaviour.
When trying to predict compliant behaviour in OSA sufferers who use CPAP therapy, it 
is apparent that the appropriate theory and psychological technology is available to 
allow for the effective investigation of such a process. Parallels can be drawn between 
the psychological issues pertinent to OSA and other chronic diseases which have 
benefited from the application of social cognition research, therefore supporting the 
need for the psychosocial evaluation of this clinical population.
Conclusions
This review has established that despite the proven efficacy of CPAP therapy in the 
treatment of OSA, compliance rates have been found to be unacceptably low. Research
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examining possible predictors of compliance has failed to reliably identify indicators 
on the basis of physical and clinical variables. Social cognition models have advanced 
the understanding of health behaviour in other chronic illness. Similarities between 
these conditions and OSA would suggest that the application of such models may 
further the understanding of compliant behaviour in CPAP users. Available research 
evidence to support this view has been discussed (Edinger et al, 1994; Hoy et al, 1999). 
In particular Wallston’s (1992) modified social learning theory may be an appropriate 
starting point for the investigation of psychosocial variables and their role in the 
prediction of compliance rates in CPAP therapy. By employing Wallston’s model, 
further understanding would be gained into the relationships between health locus of 
control, health value, the self-efficacy construct and also their combined role in the 
prediction of a specific health behaviour. It is important, both clinically and 
economically, to consider and examine whether psychosocial factors can explain an 
amount of variance in compliant behaviour in this disease. OSA and CPAP compliance 
has received a great deal of research attention, but as yet existing research approaches 
have not led to clinically applicable conclusions.
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CHAPTER 3
MAJOR RESEARCH PROJECT PROPOSAL
Psychological Factors Contributing to Compliance with Continuous Positive 
Airway Pressure Therapy for Obstructive Sleep Apnoea Syndrome
Matt Wild
Department of Psychological Medicine, University of Glasgow
48
TITLE
Psychological factors contributing to compliance with continuous positive airway 
pressure therapy for obstructive sleep apnoea syndrome.
SUMMARY
Nasal continuous positive airway pressure (CPAP) therapy is currently the treatment of 
choice for obstructive sleep apnoea (OS A) syndrome. The main symptom of this 
chronic condition is daytime sleepiness. It is also associated with premature death as a 
result of cardiovascular disease and road traffic accidents. CPAP is a highly effective 
treatment, but is reliant on high levels of compliance. However, compliance rates for 
this therapy have generally been found to be low in this clinical population.
Physical variables thought to be implicated in the low compliance rates with CPAP 
have been investigated but have thus far failed to consistently explain a significant 
amount of variance in compliant behaviour. Social cognition models have been adapted 
to other chronic diseases, such as diabetes, in an effort to explain varying compliance 
rates. These approaches have met with some success in predicting future health related 
behaviours, but as yet have not been applied to compliance issues in CPAP therapy.
The proposed study will apply a social cognition model, incorporating the concepts of 
health value, health locus of control and self-efficacy, to a sample of patients who 
attend The National Scottish Sleep Laboratory at The Royal Infirmary of Edinburgh, in 
an attempt to explain variance in CPAP therapy compliance rates.
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INTRODUCTION
OS A is a disorder of neural respiratory control and upper airway function resulting in 
repeated partial and complete occlusion of the upper airway during sleep. Although the 
main symptom is daytime sleepiness OSA has been linked to hypertension, ischaemic 
heart disease and road traffic accidents (Douglas & Polo, 1994; Simonds, 1994). CPAP 
is generally considered to be the treatment of choice for OSA (American Thoracic 
Society, 1994) due to the strong evidence of its efficacy (Douglas, 1998). However, this 
efficacy is dependent on the continued nightly use of the CPAP apparatus, for 
approximately three hours or more (Engleman et al, 1994a), as symptoms return almost 
immediately after one night without treatment (Kribbs et al, 1993).
Despite its success in relieving symptoms it has been found that compliance with this 
treatment often falls below that which provides clinical effectiveness (Waldhom et al, 
1990; Rauscher et al, 1991). A number of physical and clinical variables relating to 
CPAP therapy and OSA have been investigated, but have not satisfactorily explained 
the low rates of compliance. Such variables have included polysomnographic severity 
(Reeves-Hoche, 1994), prior sleepiness (Engleman, 1994b) and treatment side effects 
(Pepin, 1995).
As physical and clinical variables have yet to conclusively explain compliance rates, it 
follows that psychological variables may be implicated. Only one paper (Edinger et al, 
1994) has addressed this as yet. This study employed the Minnesota Multiphasic 
Personality Inventory (MMPI) and concluded that the "apnea patient’s pre-treatment 
psychological status may be useful in identifying CPAP compliers" (Edinger et al,
1994, p i 118). As far as the author is aware no further research developed as a result of 
these conclusions.
As reported above, successful treatment of OSA requires significant dedication on the 
patient’s behalf as this syndrome is rarely cured, therefore committing the sufferer to
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lifelong treatment with CPAP. This level of involvement and commitment is required in 
some other chronic disorders (e.g. diabetes). A significant body of literature exists 
which has examined compliant behaviour in diabetes sufferers and many studies have 
used social cognition models as the basis for such research. Social cognition models are 
recognised to have made a valuable contribution to the understanding of individuals 
who must perform regular health related behaviours as part of an ongoing treatment for 
a chronic disease, such as diabetes (Marteau, 1989). Given that similar and significant 
lifestyle change is required for the successful treatment of both OSA and diabetes, it 
follows that models of health behaviour which have helped to further the understanding 
of compliance issues in diabetes may also help to investigate similar matters in OSA.
Social cognition models advocate that cognitive variables are the primary determinant 
of individual social behaviour, thereby determining whether or not an individual 
practices, for instance, a health related behaviour. One such model, the health locus of 
control construct, has been widely researched in the prediction of health behaviour. It 
was developed from Rotter’s social learning theory which posits that "the potential for a 
behaviour to occur in any specific psychological situation is a function of the 
expectancy that the behaviour will lead to a particular reinforcement and the value of 
that outcome" (Rotter, 1954, p i02). As a single construct, health locus of control has 
generally been found to explain small amounts of variance in health behaviour. Shelton 
et al (1992) reported that, for health locus of control beliefs to be predictive of health 
behaviours, an individual must value their health. This is regarded as an essential 
component of the motivation to perform such behaviours. The predictive power of the 
combination of health value and health locus of control had been reported to be rather 
low (Wallston, 1991), but the pattern of results was in line with the predictions of the 
health locus of control construct. As a result of this Wallston (1992) proposed a 
modified learning theory which predicted that health behaviour was determined by 
health locus of control beliefs, health value and self-efficacy. In this theory self-efficacy 
is substituted for health locus of control as the major generalised expectancy construct.
The self-efficacy construct has been found to be powerfully predictive of health
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behaviour and implicates cognitions regarding an individual’s beliefs about their ability 
to respond to and control environmental demands and challenges.
As yet, Wallston’s (1992) modified social learning theory has not been formally tested 
and social cognition models have not been applied to the issue of low compliance rates 
with CPAP therapy. The present study will apply this theory to a population of CPAP 
users in an attempt to explain the variance in compliance behaviour, on the basis of the 
three cognitive constructs of health value, health locus of control and self-efficacy.
AIMS AND HYPOTHESES
In Wallston’s (1992) theory the locus of control is seen as a moderator variable, 
therefore (it is expected that) assuming health is a valued reinforcer for an individual, 
intemality and self-efficacy will interact to predict compliance. It is proposed that 
health locus of control beliefs are necessary, but not sufficient to perform a health 
behaviour.
Hypothesis - Compliers with CPAP therapy will demonstrate significantly greater levels 
of health value, internal locus of control and self-efficacy than non-compliers, on 
measures of health value, health locus of control and self-efficacy (i.e. The Health 
Value Scale, The Multidimensional Health Locus of Control Scale and The Generalised 
Self Efficacy Scale).
More specifically, The Multidimensional Health Locus of Control Scale (see Measures 
section) predicts that compliers will gain higher scores on measures of intemality, but 
exhibit a low score on measures of chance. The prediction for health locus of control 
relating to powerful others is less clear. Health locus of control involving powerful 
others may reflect a receptive attitude to health related advice from health professionals, 
but may also indicate a strong belief in a health professional’s ability to cure illness
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regardless of an individual’s behaviours. Therefore, compliant patients will provide a 
profile on The Multidimensional Health Locus of Control Scale of either (i) high 
intemality, low chance and low powerful others, or (ii) high intemality, low chance and 
high powerful others. Non-compliers will demonstrate low scores on measures of 
intemality.
PLAN OF INVESTIGATION 
Subjects
Adult subjects will be recruited from clinics ran by The Scottish National Sleep 
Laboratory. Inclusion criteria will include a recent clinical diagnosis of OSA syndrome, 
a score of > 8 on the Epworth Sleepiness Scale and an Apnoea/Hypopnoea Index of >
15. Subjects who are involved in any other research based in the department will be 
excluded from the study. From the available epidemiological data on OSA it is 
expected that the studied sample will be 80% male, approximately 50 years old and will 
present with a variety of additional health problems other than that of OSA, such as 
respiratory and cardiac complications.
A comparable study on which to base a power calculation to determine the required 
sample size was not found within the OSA or CPAP literature. However, by extracting 
data from similar research examining compliance issues in diabetes (Kavanagh, 1993), 
a power calculation indicated that approximately 40 subjects per group (group 1, 
compliant subjects; group 2, non-compliant subjects; total = 80) would be necessary to 
demonstrate a significant between group difference (p < .05) using a one-tailed 
independent samples r-test with 0.8 power.
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Measures
Compliance will be measured by covert time clocks contained inside each CPAP unit. 
These timers record the total hours of machine run time over the 3 month follow-up 
period. From this total a mean nightly use of the CPAP apparatus can be calculated.
Three questionnaires will be employed concurrent with Wallston’s (1992) theory.
(i) The Multidimensional Health Locus of Control Scale - Form A (Wallston et al, 
1978; Appendix 3.1). This scale provides a measure of generalised expectancy beliefs 
in relation to health along three dimensions, involving intemality (measuring the extent 
to which an individual believes the locus of control is internal), chance (measuring the 
belief in chance or external factors in determining health outcomes) and powerful 
others (measuring the belief in the control over an individual’s health by powerful 
others, particularly health professionals). The subject is asked to rate, on a scale of 1 
(strongly disagree) to 6 (strongly agree), to what extent they agree or disagree with 18 
health related belief statements.
(ii) The Health Value Scale (Lau et al, 1986; Appendix 3.2). This provides a general 
measure of the value an individual places on their health. The subject is required to 
indicate, along a scale of 1 (strongly agree) to 7 (strongly disagree), how much they 
agree or disagree with 4 health value belief statements.
(iii) The Generalised Self Efficacy-Scale (Schwarzer, 1992; Appendix 3.3). This scale 
assesses the strength of an individual’s belief in their own ability to respond to novel or 
difficult situations and to deal with any associated obstacles or setbacks. The subject is 
asked to indicate how true they believe 10 generalised self efficacy statements to be, in 
relation to themselves, along a scale of 1 (not at all true) to 4 (exactly true).
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Design
When the dependent variable is treated as continuous (i.e. hours of use [compliance] as 
measured by time clocks contained in the CPAP apparatus) the study conforms to a 
factorial between-subjects ANOVA design, with three independent variables (i.e. The 
Multidimensional Locus of Control Scale, The Health Value Scale and The Generalised 
Self Efficacy Scale). When the dependent variable is split categorically (i.e. 
discriminating between those who complied with treatment above a clinically effective 
threshold [> 3hrs. per night] and those who did not use the treatment beyond that 
clinically effective level [< 3 hrs. per night]) the design involves between-subjects 
analysis of data, including %2 and f-tests.
Procedure
Following a diagnosis of OSA and subsequent offer of CPAP, potential subjects will be 
approached by sleep laboratory staff, during the evening prior to their first CPAP trial, 
to request their consent for inclusion in the study (Appendix 4.2). This will be done by 
means of an information sheet outlining the main points of the study. Subjects who 
agree to be involved in the study will sign a consent form and be asked by a member of 
staff to complete three questionnaires. This will take approximately 15 minutes. The 
administration of these measures will be the only additional procedure that participants 
will experience in comparison with other CPAP users not involved in the study. Upon 
completion all questionnaires will initially be stored in the National Scottish Sleep 
Laboratory. Once a month these questionnaires will be collected and transferred to the 
Department of Psychological Medicine, Gartnavel Royal Hospital, Glasgow, where 
coding and analysis of the data will take place.
In accordance with standard National Scottish Sleep Laboratory procedures, subjects 
will be followed up 3 months after starting CPAP therapy. At this time compliance data 
will be obtained from covert time clocks built into the CPAP apparatus which measures 
how long the machine has been turned on for. Compliance rates will be determined by
55
calculating the mean daily use of the CPAP apparatus over the 3 month follow up 
period.
To facilitate analysis, subjects will then be allocated to either a compliant sub-group or 
a non-compliant sub-group on the basis of the information extracted from the built in 
timers. Those in the compliant sub-group will have used their CPAP apparatus for an 
amount of time per night which is considered to be clinically effective (> 3 hrs. of 
average daily use; Engleman et al, 1994a). Those in the non-compliant sub-group will 
have used their apparatus for an average of less than three hours per night.
Setting and equipment
The proposed study will recruit subjects from The National Scottish Sleep Laboratory 
at The Royal Infirmary of Edinburgh. This department provides all the necessary 
equipment to diagnose and care for patients with OSA. Therefore, the only additional 
materials required to undertake this study are the psychological measures.
Data analysis
Compliance and questionnaire data will be coded and stored on SPSS for Windows.
Analysis of the data will aim to evaluate the predictive power of Wallston’s (1992) 
theory of health behaviour and identify the effects of health value, health locus of 
control and self efficacy on CPAP compliance. Analysis will initially involve a 3-Way 
between-subjects factorial ANOVA. This analysis will be employed to establish any 
statistical significance in the main effects and interactions of the three questionnaires in 
relation to CPAP compliance (when CPAP compliance is measured as a continuous 
variable). To evaluate clinical significance (significant differences between those above 
and below the accepted cut-off for clinically effective use of CPAP), between-subjects 
analysis (%2 and unrelated t-tests) will be employed.
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PRACTICAL APPLICATIONS
CPAP therapy is a relatively expensive treatment and because it is self administered its 
efficacy relies on the patient’s willingness to use the device as advised by health 
professionals. Hence, compliance should be considered to be the main determinant for 
successful use of CPAP.
This study aims to identify, on the basis of psychological measures, individuals who are 
less likely to comply with CPAP therapy. If this proves to be successful, such 
individuals could be identified at an early stage and isolated for more intensive medical 
and nursing support. The study may also help to guide the content of such educational 
or support based interventions so that resources may be allocated in the most efficient 
manner.
TIMESCALES
It is estimated that subject recruitment and data collection will begin in March/April 
1999. It is hoped that each subject will be followed up after three months to assess 
compliance rates, therefore the collection of data and subject follow ups should be 
completed by February/March 2000. Collation and analysis of data will follow. The 
project will be written up by August 2000.
ETHICAL APPROVAL
Ethical approval has been obtained from the Lothian Research Ethics Committee for the 
study to take place within The National Scottish Sleep Laboratory (Appendix 3.4).
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EXPLANATORY STATEMENT
The following statement explains the discrepancies between the major research project 
proposal and the major research project paper.
Since this proposal was written (January, 1999) it was felt that the clinical relevance of 
the study could be improved by considering clinical and physical variables, in addition 
to psychological variables, as potential predictors of compliance with CPAP. This 
change was made to acknowledge and incorporate previous research evidence which 
had found associations between physical/clinical variables relating to OSA and 
compliance with CPAP.
To incorporate this change, the statistical analysis of the data was altered. ANOVA was 
not used as the number of potential variables involved in the analysis would not have 
allowed for an accurate interpretation of interactions. Having consulted with Professor 
Wallston a regression approach was favoured.
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CHAPTER 4
MAJOR RESEARCH PROJECT PAPER
Psychological and Clinical Predictors of Compliance with Continuous Positive 
Airway Pressure Therapy for Obstructive Sleep Apnoea: A Prospective Study
Matt Wild
Department of Psychological Medicine, University of Glasgow
Prepared in accordance with guidelines for submission to 
American Journal o f Respiratory and Critical Care Medicine (Appendix 4.1)
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ABSTRACT
Obstructive sleep apnoea (OSA) is a chronic respiratory disorder most commonly 
associated with excessive daytime sleepiness, although it has considerable association 
with increased morbidity and mortality through factors such as road traffic accidents 
and cardiovascular disease. Continuous positive airway pressure (CPAP) therapy is a 
highly effective treatment for this condition. However, compliance with this treatment 
has generally been found to be low. This places the OSA sufferer at increased risk of 
morbidity and mortality as a consequence of the above complications and associations. 
As yet, physical and clinical variables relating to OSA have failed to consistently 
explain compliance rates with this treatment. Social cognition models have been 
successful in explaining the motivation to perform health-related behaviours in other 
chronic conditions, such as diabetes. This study attempted to predict compliance with 
CPAP on the basis of a social cognition model. Wallston's (1992) modified social 
learning theory, comprising the psychological constructs of health value, health locus of 
control and self-efficacy, was applied. In addition, physical and clinical variables 
previously implicated in the prediction of compliance with CPAP were considered. 
Logistic regression analysis revealed that a model comprising health value, body mass 
index (BMI) and Epworth Sleepiness Scale scores explained a small, but significant 
amount of variance (6.1%). This combination of predictors explained 1% (R2 = .010), 
0.7% (R2 = .007) and 4.4% (R2 = 0.044) of the variance respectively. The model 
correctly identified 80% of CPAP compliers, but only 45% of non-compliers. This 
result supports previous findings that compliance with CPAP may be most productively 
researched by considering psychological, as well as physical and clinical variables. This 
bio-psychosocial approach is to be encouraged in other areas of medical research.
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INTRODUCTION
Obstructive sleep apnoea (OSA) is primarily associated with extreme daytime 
sleepiness, cognitive impairment and disturbance of mood (Cheshire et al, 1992). This 
results in markedly reduced efficiency of daytime functioning, consequently negatively 
affecting daily activities such as driving (Young, 1993). In addition to the increased risk 
of road traffic accidents, it has been suggested that OSA may be associated with 
increased morbidity and mortality as a result of hypertension (Lavie, 1999), myocardial 
infarction (Marin & Kogan, 1988) and stroke (Mohsenin & Valor, 1995). OSA, a 
condition closely associated with significant morbidity and mortality, occurs in 2 to 4% 
of the middle aged population (Young et al, 1993) and does not remit spontaneously 
(Guilleminault et al, 1981), therefore it is important that long term management is 
established.
Continuous positive airway pressure (CPAP) therapy is currently the treatment of 
choice for OSA. The efficacy of this treatment has been well documented (American 
Academy of Sleep Medicine, 2000). CPAP works by forcing the upper respiratory 
airway to remain open with a constant stream of room air blown through the nose 
during sleep via a mask or nasal prongs. However, compliance with this slightly 
cumbersome treatment has been found to be low (Engleman et al, 1994b), with daily use 
of CPAP apparatus often falling below recommended levels (Reeves-Hoche et al, 1994). 
Compliance rates have been reported to be as low as 50% (American Thoracic Society, 
1994). Three hours of use per night has been established as the minimum level at which 
clinical improvement in symptoms can be expected (Engelman et al, 1994a).
There are negative medical and financial consequences of low compliance. OSA is 
association with increased morbidity and mortality, and CPAP is a relatively expensive 
form of treatment. Therefore, much research has focused on determining the predictors 
of compliance with CPAP. The majority of this research has involved the examination 
of physical and clinical variables, such as initial disease severity and treatment side-
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effects, as potential predictors of compliance (Hoffstein et al 1992; Meurice et al, 1994). 
However, the results of this research have been contradictory (Engleman et al, 1996) 
and no set of predictors has consistently explained a significant amount of variance in 
compliance rates. For example, CPAP use has been predicted by polysomnographic 
severity (i.e. initial disease severity) in some studies (Rauscher et al, 1991; Meurice et 
al, 1994) but not others (Hoffstein, 1992; Reeves-Hoche, 1994), by levels of pre­
treatment subjective sleepiness in some (Rauscher et al, 1991; McArdle et al, 1999) and 
not in others (Engleman et al, 1994b; Kribbs et al, 1993), and by CPAP treatment side 
effects in some (Hoffstein et al, 1992; Rauscher at al, 1993) but not by others (Fletcher 
& Luckett, 1991; Pepin et al, 1995). Research has not been able to conclusively explain 
low compliance rates on the basis of physical or clinical variables.
Social cognition models advocate that cognitive variables ( i.e. beliefs held by an 
individual about for instance the state of their health) are the primary determinant of 
individual social behaviour (Conner & Norman, 1998). Such models have been 
successfully adapted and applied to health care settings. There, they have made a 
valuable contribution to the understanding of which patients will reliably perform health 
behaviours (Marteau, 1995), such as comply with a recommended diabetic regimen 
(Tillotson & Smith, 1996).
Thus, as compliance with CPAP has not yet been reliably predicted by physical or 
clinical variables, it follows that psychological factors (e.g. social cognition models) 
may contribute some explanatory variance. Evidence for this hypothesis so far is 
limited. Edinger et al (1994) used the Minnesota Multiphasic Personality Inventory 
(MMPI) to evaluate OSA patients' psychological status prior to initiation of CPAP 
therapy. They concluded that personality measures (i.e. the MMPI) may be useful in 
predicting long-term compliance with this treatment. More recently, Hoy et al (1999) 
reported that CPAP use was significantly greater in patients who initiated their own 
referral for treatment of symptoms relating to OSA. This also suggests that pre­
treatment psychological status may be an important predictor of compliance with CPAP.
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A model proposed by Wallston (1992) incorporated three well established constructs 
(i.e. health value, health locus of control and self-efficacy) in an attempt to explain 
health-related behaviour.
The health locus of control construct, has been widely researched in the prediction of 
health behaviour. It was developed from Rotter's social learning theory which posits that 
"the potential for a behaviour to occur in any specific psychological situation is a 
function of the expectancy that the behaviour will lead to a particular reinforcement and 
the value of that outcome" (Rotter, 1954, p i 02). As a single construct, health locus of 
control has generally been found to explain small amounts of variance in health 
behaviour. Shelton et al (1992) reported that, for health locus of control beliefs to be 
predictive of health behaviours, an individual must first value their health. This health 
value construct is regarded as an essential component of the motivation to perform such 
behaviours. The predictive power of the combination of health value and health locus of 
control had been reported to be rather low (Wallston, 1991), but the pattern of results 
were in line with the predictions of the health locus of control construct. Consequently, 
Wallston (1992) proposed his modified learning theory which predicted that health 
behaviour was determined by high measured levels of health locus of control beliefs, 
health value and self-efficacy. In this theory self-efficacy is substituted for health locus 
of control as the major generalised expectancy construct. The self-efficacy construct has 
been found to be powerfully predictive of health behaviour and implicates cognitions 
regarding an individual's beliefs about their ability to respond to and control 
environmental demands and challenges.
In the present study, Wallston's (1992) modified social learning theory was applied to a 
population of patients with OSA prior to initiation of CPAP therapy, in order to 
investigate whether psychological factors may usefully contribute to the prediction of 
subsequent compliance with this form of treatment. In addition, demographic, physical 
and clinical data were considered as possible predictors. These variables were included
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so as to take account of previous research evidence highlighting their potentially 
important contribution and also to avoid an unnecessary and potentially less 
environmentally valid focus on purely psychological factors.
METHODS 
Subjects
During the twelve month study period all patients being offered CPAP by the Scottish 
National Sleep Laboratory were invited to participate. During this period 162 patients 
agreed to be involved. One hundred and twenty complete sets of data were gathered 
from these subjects (i.e. 74.1% of initial sample). Subjects were excluded from the 
study if they were found already to be participating in other current research projects in 
the department (n = 4, 2.5%). Twenty subjects (12.3%) could not be contacted 
following non-attendance at a follow up clinic and a further 6 subjects (3.7%) had 
moved outwith the catchment area of the service. Nine subjects (5.5%) filled out 
questionnaire based information incorrectly, or did not provide enough information to 
be included in the study. Three subjects (1.9%) had faulty time clocks on their CPAP 
apparatus. Their compliance data were not used. The follow up rate was therefore 
74.1%.
Diagnosis
Patients were evaluated for possible OSA through clinical interview, physical 
examination and nocturnal sleep study by a physician experienced in sleep medicine.
The decision to offer CPAP was based on the presence of at least two major symptoms 
of OSA, plus an Apnoea/Hypopnoea Index (AHI) of greater than 15 events per hour of 
sleep and an Epworth Sleepiness Scale score of more than 8. This measure (Johns,
1991) is an eight item self-reported rating scale (from 0 = no chance of falling asleep, to
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3 = high chance of falling asleep) of how likely an individual feels they are to fall asleep 
in a number of every-day situations (e.g. while watching television, while sitting and 
talking to someone). Scores range from zero to a maximum of twenty four.
Measures
Compliance
Covert time clocks contained inside each CPAP unit were used to monitor compliance 
rates. The timers recorded the total run time (in hours) of each machine. These timers 
were read at a three month follow-up appointment so as to establish the mean nightly 
use of the CPAP apparatus (in hours).
Early studies investigating CPAP compliance were based on patient report, however 
self-reports are now considered to be unreliable for assessing CPAP use. Time clocks 
were used in this study to provide an objective measure of compliance as it has been 
demonstrated that OSA patients consistently overestimate their CPAP use (Collard et al, 
1997) and that self-reports are unable to distinguish between compliers and non- 
compliers (Rauscher et al, 1993).
Psychological Measures
Three psychological measures were used in accordance with Wallston's (1992) modified 
learning theory.
The Multidimensional Locus of Control Scale - Form A (Wallston et al, 1978;
Appendix 3.1). This scale provides a measure of generalised expectancy beliefs in 
relation to health along three dimensions, comprising intemality (i.e. measuring the 
extent to which an individual believes the locus of control is internal), chance (i.e. 
measuring the belief in chance or external factors in determining health outcomes) and 
powerful others (i.e. measuring the belief in the control over an individual's health by 
powerful others, particularly health professionals). The subjects were asked to rate, on a
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scale of 1 (strongly disagree) to 6 (strongly agree), to what extent they agreed or 
disagreed with 18 health-related belief statements. Alpha reliability for each of the 
scales has been reported to range from .67 to .77.
The Health Value Scale (Lau et al, 1986; Appendix 3.2). This provides a general 
measure of the value an individual places on their health. The subjects were required to 
indicate, along a scale of 1 (strongly agree) to 7 (strongly disagree), how much they 
agreed or disagreed with 4 health value belief statements. The internal consistency of 
this scale is .67 (Cronbach's alpha).
The Generalised Self Efficacy Scale (Schwarzer, 1992; Appendix 3.3). This scale 
assesses the strength of an individual's belief in their own ability to respond to novel or 
difficult situations and to deal with any associated obstacles or setbacks. The subjects 
were asked to indicate how true they believed 10 generalised self efficacy statements to 
be, in relation to themselves, along a scale of 1 (not at all true) to 4 (exactly true). The 
alpha reliability of this scale ranges from .82 to .93.
Procedure
The subjects involved in the study received identical treatment to other patients not 
recruited into the study. The only difference being that those involved in the present 
study were required to fill out three psychological questionnaires. On average these took 
ten minutes to complete.
Having been diagnosed with OSA and agreed to accept CPAP treatment, all potential 
subjects were given the option of participating in the current study. They were given a 
consent form (Appendix 4.2) and it was stressed that their decision to participate or not 
participate in the study would in no way affect their subsequent clinical treatment in the 
department. Having signed the consent form all subjects were then asked to complete 
the three psychological measures. This was the only additional procedure that the
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participants were required to perform in comparison to other CPAP users. The 
psychological measures were completed prior to any experience of CPAP treatment.
Having completed the psychological measures, all patients received education about 
CPAP prior to a titration night (i.e. a trial night of CPAP when the specification of the 
apparatus is set-up for the individual user). This comprised an explanation of the 
treatment process by a nurse specialist, a mask fitting, an educational video and a 20 
minute daytime trial with the full CPAP apparatus. CPAP treatment following this 
educational process was home-based. The titration night was the only hospital-based 
CPAP treatment procedure.
Following titration and having commenced home-based treatment, patients were 
contacted at home by a nurse specialist within the first two weeks of CPAP use to 
enquire about any on-going problems regarding the apparatus (e.g. mask-fit, nasal 
congestion, skin irritation). Difficulties were addressed as appropriate. All patients were 
then contacted three months after starting CPAP and offered a follow-up clinic 
appointment. At this review patients were asked about positive treatment-effects and 
side-effects of CPAP. Time clocks were also read at this appointment to establish the 
average nightly rate of use. Patients who failed to attend their clinic appointment were 
contacted by phone and asked to report the time clock reading themselves.
Having gained compliance data from a subject, further information was gathered from 
their medical notes to provide a full set of data. Further information comprised 
demographic (e.g. age, gender), clinical (e.g. AHI) and physical (e.g. BMI) data.
Hypotheses
It was hypothesised that, in line with Wallston's (1992) modified social learning theory, 
subjects who complied with CPAP therapy would display higher scores on the three 
psychological measures than those subjects who did not comply with CPAP therapy.
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More specifically, the Multidimensional Health Locus of Control Scale predicts that 
compliers will gain higher scores on measures of intemality, but exhibit a low score on 
measures of chance. The prediction for health locus of control relating to powerful 
others is less clear. Health locus of control involving powerful others may reflect a 
receptive attitude to health related advice from health professionals, but may also 
indicate a strong belief in a health professional's ability to cure illness regardless of an 
individual's behaviours. Therefore, compliant patients were expected to provide a 
profile on the Multidimensional Health Locus of Control Scale of either (i) high 
intemality, low chance and low powerful others, or (ii) high intemality, low chance and 
high powerful others. Non-compliers were expected to demonstrate low scores on 
measures of intemality and high scores on measures of chance.
Other potential demographic, physical and clinical factors were also considered as 
potential predictors of compliance. However, due to conflicting previous research 
findings, no predictions regarding specific variables or directions of association were 
made.
Statistical Analysis
Potential between group differences were investigated by means of independent /-tests 
(interval data) or chi-square (nominal data) for data which were normally distributed. 
Mann-Whitney U tests were used to investigate differences in data which were not 
normally distributed (i.e. AHI, CPAP pressure, use of alcohol). These analyses were 
used to select potential predictors of compliance with CPAP.
The main aim of the study was to consider the predictive value of Wallston's (1992) 
modified social learning theory in relation to other potential predictors to establish the 
best set of predictors of compliance with CPAP. Therefore, the main analysis took the 
form of logistic regression. This type of analysis aims to the predict the membership of 
a categorical dependent variable (in this case, compliant/non-compliant, as this is the
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most clinically relevant variable) on the basis of categorical or continuous independent 
variables. The compliant/non-compliant split was made at 3 hrs. of use per night as this 
is known to be the lower threshold of clinically effective use (Engleman et al, 1994a). In 
this study psychological variables were first considered as possible predictors of 
eventual compliance, after which, physical and clinical variables (e.g. AHI, BMI, CPAP 
side-effects) were considered which had been implicated in the prediction of compliance 
in previous research. Wallston (1998) advocates a regression approach whereby the 
predictive variables used are continuous variables, rather than an ANOVA approach 
which would require the use of discrete variables.
RESULTS 
Study Population
Summary demographic and clinical information on the total sample (n = 120) and the 
compliant (n = 69, > 3 hrs. of use per night) and non-compliant (n = 51, < 3 hrs. of use 
per night) sub-groups is presented in Table 1.
Levels o f Compliance
The mean rate of compliance for the total sample was 3.6 hrs. of use per night. Using 
the clinically effective compliance cut-off rate (3 hrs; Engleman, et al 1994a), it can be 
seen that more than half of the total sample complied with CPAP treatment. Mean daily 
CPAP use in the compliant sub-group (5.8 hrs. of use per night) was comparable with 
previously reported use in a similar OS A population (McArdle et al, 1999; Mean = 5.7, 
Interquartile Range = 3.9 to 7.0)
Demographic Information
The population was primarily male with a mean age of 51 years. The sample was 
generally married and employed. Of those not working, many were retired due to ill
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health. These demographic patterns were reflected in the compliant and non-compliant 
sub-groups and there were no significant differences between groups.
Current Medication
Almost half of the total population were receiving medication for cardiovascular 
disease. Twenty percent were on medication for chronic pain, with a similar proportion 
currently taking psychoactive medication, mostly in the form of antidepressants (SSRI).
The pattern of psychoactive medication use was positively skewed in the direction of 
the compliant sub-group. However, no significant difference between groups was 
observed. It can be seen that nineteen of the total population were receiving medication 
for concurrent respiratory disorders.
Intervention Received
Intervention regarding CPAP side-effects and mask fit was relatively low. Five 
participants required an additional chin strap to prevent the mask slipping during the 
night. The same number was recommended to use a decongestant to address the 
problem of nasal stuffiness. Twelve participants required a change of mask. None of the 
non-compliant sub-group received the chin strap intervention.
Use o f Alcohol and Tobacco
Over half of the total sample were smokers. On average they consumed around eight 
units of alcohol per week.
Insert Table 1 here
Selection of Potential Predictors of CPAP Compliance Based on Comparison of 
Compliant and Non-Compliant Sub-Group Data
Selection of potentially predictive variables for inclusion in the initial logistic regression 
analysis was based on Hosmer & Lemeshow (1989). They advocate a less stringent
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criterion than p < .05 (for between group differences) for the selection of variables in the 
analysis so as to avoid the misinterpretation of excluded variables. They present the case 
that a predictive variable might be excluded from the final model even though it is 
highly correlated with the dependent variable, but is removed because of co-linearity 
with one or more of the other independent variables. So, to avoid the potential for Type 
II error they suggest that a p < .20, rather than p < .05, is more likely to ensure the entry 
of coefficients which differ from zero.
The total sample was split retrospectively into compliant and non-compliant sub-groups 
on the basis of compliance data. Between group differences were examined in order to 
select potential predictive variables for inclusion in the logistic regression analysis 
based on the above selection criteria.
Demographic Variables
When the demographic data from the compliant and non-compliant sub-groups were 
compared it was found that they generally reflected the patterns of distribution 
displayed by the total population. No significant differences were observed. The 
selection criteria for inclusion in the logistic regression analysis was not met by any of 
these variables.
Medication and Intervention Variables
Potential differences between the sub-groups on the basis of categorical variables were 
examined. No statistically significant differences were observed on the basis of these 
comparisons. However, it was noted that a greater number of compliers than non- 
compliers received a chin strap intervention (x2 = 3.8, p = .07) and more compliers were 
receiving psychoactive medication while using CPAP (x2 = 2.5, p = .15). These two 
variables fulfilled the selection criteria for inclusion in further analysis.
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Physical Variables
Comparison of the two sub-groups in terms of physical and clinical presentation (i.e. 
BMI, alcohol consumption), disease severity (i.e. AHI, minimum O2 saturation, 
Epworth Sleepiness Scale scores) and data relating to CPAP treatment (i.e. CPAP 
pressure) revealed that the compliant sub-group displayed higher Epworth Sleepiness 
Scale scores and significantly higher pre-treatment AHI (p < .05) and BMI (p < .01) 
values than the non-adherent sub-group (see Table 2). This suggests that the clinical 
effects of OSA were more severe in the compliant sub-group. However, these values 
were within the typical range of the OSA population and of those who attend the 
National Sleep Laboratory (Hoy et al, 1999; McArdle et al, 1999). The following 
variables met the selection criteria for inclusion in the logistic regression analysis; 
Epworth Sleepiness Scale scores, alcohol consumption, minimum O2 saturation and 
BMI.
Insert Table 2 here
Psychological Variables
Comparison between the compliant and non-compliant sub-groups on the basis of 
psychological variables revealed no significant differences (see Table 2). However, it 
should be noted that the compliant and non-compliant sub-groups displayed markedly 
lower (i.e. up to two standard deviations below) health value scores in comparison with 
scores obtained from other chronic clinical and a non-clinical populations (see Table 3). 
These deflated score patterns were not observed in the other psychological variables. 
Between group comparison revealed that compliers displayed greater health value 
scores than non-compliers. The health value variable met the criteria for inclusion in the 
logistic regression analysis.
In accordance with the research hypothesis (i.e. the compliant sub-group will display 
generally higher scores than non-compliant sub-group on the psychological measures) a 
median split was used to establish a cut-off point for the psychological variables. Using
75
these cut-offs, subjects were then categorised, in accordance with Wallston's (1992) 
model, as compliant or non-compliant on the basis of their psychological profile. No 
significant difference between these two groups was observed on the basis of 
compliance data.
Insert Table 3 here
To summarise, it has been demonstrated that the study population is typical of the 
general OSA population and comparable with other study populations who have 
attended the National Sleep Laboratory. Potential important differences were found to 
exist between the compliant and non-compliant sub-groups on a number of physical 
variables and on scores of health value. Therefore, initial inclusion in the logistic 
regression analysis included the following variables; Epworth Sleepiness Scale score, 
alcohol (units, per week), AHI, minimum O2 saturation, BMI, chin strap intervention, 
psychoactive medication and health value score (see Table 2).
Insert Table 4 here
A model was then built with the intention of establishing the combination of variables 
which best predicted compliance with CPAP treatment. Variables were removed if they 
contributed no additional explanatory variance (R) to the prediction of compliance. The 
results of this analysis are shown in Table 4.
As can be seen, a model comprising health value scores, Epworth Sleepiness Scale 
scores and BMI values was found to be the best predictor of CPAP compliance. The 
model correctly identified 80% of CPAP compliers, but correctly allocated only 45% of 
non-compliers. A small, but significant amount of variance was explained by the model 
as a whole (6.1%). Health value scores, Epworth Sleepiness Scale scores and BMI 
values explained 1% (R2 = .010), 0.7% (R2 = .007) and 4.4% (R2 = 0.044) of the variance 
respectively. All the variables were predictive of compliance in the expected direction.
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DISCUSSION
The main aim of the present study was to investigate whether psychological factors play 
a role in the prediction of compliance with CPAP. Results indicated that a model 
comprising high health value, BMI and Epworth Sleepiness Scale scores was most 
predictive of compliant behaviour. This result complements the findings of Edinger et al 
(1994), who found that 62% of the total variance in compliance with CPAP was 
explained by a combination of high scores on hypochondriasis and depression scales 
from the MMPI, high values of BMI and high ratings of subjective daytime sleepiness. 
This result also supports the findings of Hoy et al (1999). They reported that a major 
determinant of CPAP use was whether the patient or the patient's partner initiated the 
referral for treatment of OSA. Although this was not interpreted from a psychological 
perspective, it represents farther evidence that non-clinical variables may contribute to 
the prediction of compliance with CPAP. It would seem that the health value construct 
may be common to all of these findings.
Health value has been posited as an essential and primary component of the motivation 
to perform a health-related behaviour, for example, as in this study, comply with CPAP 
therapy (Lau et al, 1986). Accordingly, for an individual to engage in a health- 
promoting behaviour they must first value their health. In the Edinger et al (1994) paper, 
preoccupation with health (hypochondriasis) was implicated in the prediction of 
compliance. It would be expected that to be hypochondriacal, one must first value ones 
health. In Hoy et al (1999), spontaneous health-seeking behaviour was predictive of 
compliance. Again, this finding would suggest that those who sought referral already 
valued their health. In the current study higher health value scores were associated with 
greater levels of compliance. Therefore, it can be seen that although labelled differently, 
the construct of health value could be central to all of the above findings. In other words 
health is highly valued by compliers in these study samples.
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Despite the finding that health value is implicated in the prediction of compliance with 
CPAP, the work of Lau et al (1986), who have conducted most of the research in this 
area, would suggest that additional psychological factors should also be considered as 
possible motivators. This view may be supported in this study as health value explained 
only a small amount of the overall variance in compliant behaviour.
In line with this theory, the predictive value of Wallston's (1992) modified social 
learning theory (comprising health value, health locus of control and self-efficacy) was 
evaluated. However, as a model, it was found that this combination of psychological 
variables did not usefully predict compliance with CPAP in the study population. Scores 
obtained on measures of self-efficacy and health locus of control did not differentiate 
between compliers and non-compliers. These variables did not fulfil the criteria for 
selection in further analysis and were assumed not to be implicated in the prediction of 
compliance. Further research will be required to investigate other possible psychological 
determinants of compliance with CPAP. This may lead to the explanation of more 
behavioural variance, further increasing the efficiency of the predictive model proposed 
in this study.
Although health value was associated with the prediction of compliance, actual scores 
were significantly lower than those found in other populations. Behavioural theory may 
partly explain this finding. The concept of learned helplessness (Seligman, 1975), which 
describes the acquired sense that one can no longer control one's environment so that 
one gives up trying, may partially explain reduced health value in the OSA population. 
OSA is typically associated with a variety of other chronic health complaints, including 
respiratory and cardiovascular disease. These significant, concurrent threats to health are 
perhaps more serious than would be expected in the health value comparison population 
(i.e. ulcer clinic patients; Lau et al, 1986). Therefore, as a result of significant 
experience of chronic illness, the OSA population could have learned that they have 
limited control over their own health. In turn, this may have resulted in generally 
reduced concern about health-related matters (i.e. lower health value scores). However,
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as in the general population, health value varies considerably. Thus, some individuals 
retain a relatively high health value despite their experiences, perhaps as a function of 
other psychological factors. These individuals represent the CPAP compliant sub-group.
This behavioural interpretation may also explain the high prevalence of depression 
observed in the study sample (i.e. 18.2% on psychoactive medication, as compared with 
5% prevalence of depression in the general population; Sturt et al, 1984). Learned 
helplessness (Seligman et al, 1976), and more specifically, negative attributional style 
(Abramson et al, 1978) has been implicated in the development and maintenance of 
depression.
The inclusion of BMI and Epworth Sleepiness Scale scores in the model of compliance 
supports a recent finding that patients with less severe OSA are less likely to comply 
with CPAP treatment (Janson et al, 2000). In the present study it was found that 
compliers were generally less healthy and more affected by OSA (i.e. higher BMI 
values, greater levels of subjective sleepiness, higher initial AHI) than non-compliers. 
This finding would seem to argue against the above explanation that those with more 
experience of illness have learned to place a lower value on their health and are 
therefore less likely to comply with treatment. However, it may be that those with 
greater OSA symptoms have more to gain by complying with CPAP treatment. A clear 
explanation cannot be confirmed by these data, but it would seem that, as mentioned 
previously, health value alone does not entirely predict compliance. This behaviour 
would seem to be mediated by other, as yet unidentified psychological variables.
Potential criticisms of this study include a possible sampling bias resulting from the 
relatively low follow-up rate (74%). However, the reasons for not obtaining a full data 
set were unrelated to non-compliance with CPAP. For instance, non-attendance at a 
follow-up clinic cannot be assumed to indicate low levels of compliance. Other reasons 
included valid, uncontrollable, but common factors (e.g. subjects moved away from the 
study area, faults occurred in CPAP equipment, questionnaires were filled out
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incorrectly). Furthermore, it has been demonstrated that the study sample was typical of 
the general OSA population and other study samples recruited from the same centre (see 
McArdle et al, 1999). Thus, it is unlikely that any significant sampling bias exists within 
the study sample.
Disease specific psychological measures were not used in this study. This may partly 
explain the lack of significance found in the results relating to these scales. It has been 
suggested that generalised measures may be less sensitive to the cognitive processes 
underlying a health behaviour. However, the use of disease specific measures would not 
have been appropriate. Firstly, the study aimed to examine predictors of CPAP 
compliance, not the patients' ability to cope with OSA itself. Therefore, OSA specific 
measures would have evaluated inappropriate cognitive processes. Secondly, at the time 
of measurement, patients had not used the CPAP apparatus clinically. Therefore, 
patients had no prior experience of the apparatus upon which to base specific beliefs. A 
retrospective study using disease specific measures would be possible, although the 
potential measurement biases relating to such a design would then be introduced.
A small amount of variance was explained by the predictive model (see ^-values, Table 
4). Alone, on the basis of statistical evidence, it would seem that this model's potential 
for predicting compliance with CPAP is limited. However, it can be argued that this 
model demonstrates clinical significance. Firstly, these results represent similar 
conclusions to those drawn by Edinger et al (1994). This study explained 62% of the 
overall variance, based on very similar variables to the present study, with only the 
addition of a depression scale. This is the only other study to have specifically examined 
pre-treatment psychological status. Secondly, despite the small amount of explanatory 
variance, this model correctly identified 80% of compliers making this a clinically 
significant result with the potential to inform clinical practice. Kendall (1999) advocates 
that clinical significance, not just statistical significance is an important factor to 
consider in the interpretation of data. However, caution must be exercised in 
interpreting or implementing such a finding, as the obtained results (i.e. the predictive
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model) will always fit the data provided by the study sample better than the general 
population.
Overall, the results of this study provide further evidence that psychological factors 
contribute to CPAP compliance. As a consequence of these results it may be possible to 
implement an intervention study based on some of the above findings aimed at 
increasing compliance with CPAP. Findings suggest that cognitive constructs and 
beliefs are involved in the motivation to comply with CPAP treatment. Such constructs 
are not believed to be stable personality traits, but can and do change over time as a 
consequence of intervening experiences, such as ill-health (Wallston, 1998; Lau et al,
1986). Previous studies have demonstrated that compliance with CPAP can be improved 
through interventions such as intense clinical support (Hoy et al, 1999) and group 
education (Likar et al, 1997). However, these studies were not psychologically informed 
and the mechanism of improvement was not systematically evaluated. An intervention 
study targeting health value related cognitions, would further evaluate the role of 
psychological factors in compliance with CPAP and would also investigate the 
possibility of increasing levels of compliance through the manipulation of health-related 
cognitions.
In addition to highlighting the importance of psychological variables in the prediction of 
health-related behaviours, these results also support the need for a wider focus in 
medical research. By taking a bio-psychosocial approach to the evaluation of predictors 
of compliance with CPAP (i.e. considering psychological variables as well as physical 
and clinical variables), it has been possible to further the understanding of this 
behaviour and open up future directions for research. Such findings would not have 
been obtained if a restricted focus on either physical variables, or psychological 
variables had been implemented.
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CHAPTER 5
SINGLE CASE RESEARCH STUDY
Successful Treatment of Idiopathic Hypersomnia with Modafinil (Provagil): A
Paediatric Single Case Trial
Matt Wild
Department of Psychological Medicine, University of Glasgow
Prepared in accordance with guidelines for submission to 
Developmental Medicine and Child Neurology (Appendix 5.1)
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ABSTRACT
Modafinil has proved to be effective in the treatment of idiopathic hypersomnia (i.e. a 
condition typified by extreme daytime sleepiness and associated cognitive deficits) in 
the adult population. Currently, there is little systematic research which has evaluated 
its efficacy in the paediatric population. In this case study, a 15 year old male with 
idiopathic hypersomnia received modafinil as treatment for his condition. A single­
blind, placebo-controlled trial was conducted over a seven week period. Clinical 
improvement of symptoms was reported and observed during treatment with modafinil. 
In addition, a positive treatment effect was observed on cognitive measures of 
attention/concentration, vigilance, speed of information processing and reaction time. 
This single-case trial provides some evidence for the efficacy of modafinil in the 
treatment of idiopathic hypersomnia in the paediatric population. Larger scale 
systematic studies are recommended.
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Appendix 1.1 - Guidelines for submission to Health Bulletin
N o tes  fo r  C o n tr ib u to rs
P ap ers, a r tic le s  and oth er con tr ib u tion s sh ou ld  be sen t to the E d itor . H ealth  B u lle t in .  
S c o tt ish  O ff ic e  D epartm ent o f  H ealth. Rootn 1 4 3 .'St A n d rew 's  H ou se . Edinburgh EH I 
3 D E . T h e y  m ust be su b m itted  e x c lu s iv e ly  for H ealth  B u lle t in . A c c e p ta n c e  is on the  
u n derstand ing  that editorial rev ision  may be n ecessary . A ll papers are r ev iew ed  by the  
Editor and by peer review , referees being drawn from a panel o f  appropriate p ro fession a ls  
in the N H S  in S co tla n d . N o  co rresp o n d en ce  can be en tered  in to  ab ou t a r tic le s  fou n d  
un suitable and returned to authors.
M ateria l su b m itted  for p u b lica tion  m ust be ty p ew ritten  on o n e  s id e  o f  the pap er o n ly ,  
in d ou b le  spacing and with adequate margins and each page should  be num bered. T he top  
typed c o p y  should be subm itted, w ith four other c o p ie s . A ll papers sh ou ld  be p refaced  by  
a stru ctu red  A bstract, o f  about 2 5 0  w ords in length . It sh ou ld  norm ally  con ta in  6 c le a r ly  
head ed  se c tio n s  entitled  O b jec tiv e . D esig n . S e ttin g . S u b jec ts . R esu lts  and C o n c lu s io n .  
T he n a m e, appointm ent and p lace o f  work o f  the authors shou ld  be su p p lied  on a separate  
title p a g e . T his sam e page shou ld  include the full postal address o f  one author. to w hom  
corresp ondence and reprints w ill be directed. There shou ld  be adequate references to any 
relevant previous work on the subject: these referen ces should  appear at the end o f  the 
material on  a separate page or pages, using the V ancouver sty le , w hich  in the case  o f  papers 
in jou rn als includes:
Surnam e and initials o f  authur(s)
T itle  o f  paper 
Full nam e o f  Journal 
Y ear published  
V o lu m e  number
O p en in g  and closin g  page numbers
R e f e r e n c e  to  b o o k s  s h o u l d  s i m i l a r l y  i n c l u d e  a u t h o r ' s  n a m e  a n d  i n i t i a l s ,  ful l  t i t le ,  e d i t i o n  ( i f  
n e c e s s a r y ) ,  p l a c e  o f  p u b l i c a t i o n ,  p u b l i s h e r ' s  n a m e ,  y e a r ,  a n d  i f  r e q u i r e d  v o l u m e  n u m b e r ,  
c h a p t e r  n u m b e r  o r  p a g e  n u m b e r .
S h o r t  C o m m u n i c a t i o n s .  T h e  B u l l e t i n  n o w  p u b l i s h e s  s h o r t  c o m m u n i c a t i o n s  ( n o t  
e x c e e d i n g  t h r e e  p a g e s  in l e n g t h )  as  a s e p a r a t e  s e c t i o n ,  a n d  w e  a i m  to o t t e r  s p e e d i e r  
p u b l i c a t i o n  for  t he se .  M a t e r i a l  i n t e n d e d  for  thi s  s e c t i o n  s h o u l d  b e  s u b m i t t e d  in t he  a b u s e  
f o r m,  a n d  t he  c o v e r i n g  le t t e r  s h o u l d  s t a t e  t he  i n t en t i on .
C o p y r i g h t .  T h e  ma t e r i a l  in H e a l t h  Bu l l e t i n  is c o p s  r i gh t .  I t e ms  m a y  be  f r ee  Is r e p r o d u c e d  
in  p r o f e s s i o n a l  j o u r n a l s ,  p r o v i d e d  t h a t  s u i t a b l e  a c k n o w l e d g m e n t  i s  m a d e  a n d  t h a t  
r e p r o d u c t i o n  is n o t  a s s o c i a t e d  svi th a n y  f o r m  o f  a d v e r t i s i n g  m a t e r i a l .  In o t h e r  c a s e s ,  
p e r m i s s i o n  t o  r e p r o d u c e  e x t r a c t s  s h o u l d  b e  s o u g h t  t h r o u g h  t h e  E d i t o r  f r o m  H . VI S O  
P u b l i s h i n g  D i v i s i o n  ( C o p y r i g h t  S e c t i o m .  svhich c o n t r o l s  t he  c o p y r i g h t .
P ro o fs
C o n t r i b u t o r s  w i l l  r e c e i v e  o n e  se t  o f  p r o o f s .  !l s h o u l d  b e  r e a d  c a r e f u l l y  ft.*; p r i m e r ' s  e r r o r s ,  
a n d  a n y  t a b l e s ,  f i g u r e s  a n d  l e g e n d s  s h o u l d  b e  c h e c k e d .  A l t e r a t i o n s  s h o u l d  h e  k e p t  to  a  
m i n i m u m ,  a n d  th e  p r o o f s  s h o u l d  b e  p r o m p t l y  r e t u r n e d .
R e p r i n t s
O n e  h u n d r e d  r epr i n t s  wi l l  oc  s u p p l i e d  f ree o f  c h a r g e .  A l i mi t e d  e x t r a  n u m b e r  1 w h i c h  a 
c h a r c e  w i l l  be  m a d e i  m a y  be  o r d e r e d  f r om the  E d i t o r  w h e n  the  p r o o f s  a r e  r e t u r n e d .
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Appendix 1.2 - Semi-structured interview
Name - 
Department -
Position held in department - 
How long position held -
Q1 - Are you aware that The Department of Clinical Psychology offers potential input 
to all medical and surgical departments within the hospital?
Q2 - How did you become aware of the service?
Q3 - Please rate how important you consider the service to be to the care of patients 
within your department? (rating 1-10, 1= not important at all, 10= of vital importance)
Q4 - Do you refer patients to the service? If YES go to (5), if NO go to (7)
Q5 - Roughly how many patients would you refer to the service in an average year? 
1-5,6-10, 11-15, 16-20
Q6 - Do you think you are currently making full use of the service? Now go to (8)
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Q7 - Do any of the following reasons identify why you may not have referred to the 
service in the past?
a) You do not have enough information about psychological services offered 
to your department
b) You do not have enough information about the role of clinical psychologists 
within the hospital
c) You do not consider the service to be of relevance to your department
d) You do not consider clinical psychologists to have a role in the care of 
patients attending medical and surgical departments
e) You consider that waiting lists may be too long
f) You considered referral to another agency (psychiatry, GP, social work, OT) 
would be most appropriate in the first instance
g) Other (please specify)
Q8 - What would you consider to be an acceptable waiting time for a clinical 
psychologist to make contact with your patient, following
a) an urgent referral
b) a routine referral (number of days, weeks, months)
Q9 - Can you give an example/examples of services the department may offer medicine 
and surgery?
Q10 - Please indicate on Handout A which services you think are offered by the 
department.
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Q11 - Please indicate on Handout B how relevant you consider these services might be 
to medical and surgical departments, (rating 1-10, 1= extremely relevant, 10= totally 
irrelevant)
Q12 - Which of the following factors do you think might be involved in your decision 
whether or not to refer to the service:
a) Waiting times for treatment
b) Family’s motivation for the patient to seek psychological support
c) Patient’s motivation to seek psychological support
d) Presence of physical symptomatology
e) New diagnosis of a serious illness
f) Knowledge of a member of staff at the department of clinical 
psychology
g) Good outcome from a previous referral
h) Other (please specify)
Q13 - Do you see a possible role for clinical psychology to be involved with patients in 
your care in the future?
Q 14 - Do you see a role for a clinical psychologist in any of the following areas within 
your department?
a) One-to-one patient contact
b) Contact with patients in a ward setting
c) Consultative role with staff in your department
d) Work with groups of patients
e) Support for carers and staff 
- Are there any others?
Handout A
Advice about compliance with treatment
Behavioural management
Adjustment to life events
Hypnotherapy
Pain management
Neuropsychological assessment
Relaxation techniques
Illness prevention
Advice about medication
Psychological preparation for physical treatment
Handout B
Advice about compliance with treatment
Behavioural management
Adjustment to life events
Hypnotherapy
Pain management
Neuropsychological assessment
Relaxation techniques
Illness prevention
Advice about medication
Psychological preparation for physical treatment
Q 15 - Do you feel you have enough information about the service?
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Q16 - Would you like further information about what the service could offer your 
department?
Q17 - Would you be interested in occasional talks by a clinical psychologist to groups 
of professionals working in your department?
Q18 - Any other comments?
Appendix 1.3 - Letter sent to chief consultant (consent letter)
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MW/JB
Mr. M. Wild
13/03/98
Dear
I am a psychologist currently pursuing a Doctorate in Clinical Psychology at the 
Department of Psychological Medicine, University of Glasgow. While at Hospital, 
as part of my training I am required to submit a service related research project. I have 
chosen to evaluate staff attitudes and perceptions of need towards the service offered by 
the Clinical Psychology Department at Hospital to all medical and surgical
departments on issues relating to the provision of this service. This will take the form of 
a semi-structured interview. I am very aware of pressure of time, so the interview has 
been designed to last no longer than thirty minutes. Perhaps you could nominate a 
representative from your department to take part in this study. This person would need 
to have knowledge of referral practices within your department. I will contact the 
department soon to collect the name of the nominated representative. This project has 
been approved by the Head of the Clinical Psychology Department at 
Hospital, Dr.
If you require any further information please do not hesitate to contact me at the 
department.
Thank you in advance for your interest and co-operation.
Yours sincerely,
MR. M. WILD
TRAINEE CLINICAL PSYCHOLOGIST
general/mwssrcon/jb
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Appendix 1.4 - Information and instructions sent to departmental representatives
MW/JB
Mr. M. Wild
13/03/98
Dear
I am a psychologist currently pursuing a Doctorate in Clinical Psychology at the 
Department of Psychological Medicine, University of Glasgow. While at Hospital, 
as part of my training I am required to submit a service related research project. I have 
chosen to evaluate staff attitudes and perceptions of need towards the service offered by 
the Clinical Psychology Department at Hospital to all medical and surgical
departments on issues relating to the provision of this service. This will take the form of 
a semi-structured interview. I am very aware of the pressure on your time, so the 
interview has been designed to last no longer than thirty minutes. You have been 
nominated as your department’s representative as you have knowledge of referral 
practices within your department. I will contact you soon to arrange a convenient time 
for us to meet. This project has been approved by the Head of the Clinical Psychology 
Department at Hospital, Dr.
If you require any further information please do not hesitate to contact me at the 
department.
Thank you in advance for your interest and co-operation.
Yours sincerely,
MR. M. WELD
TRAINEE CLINICAL PSYCHOLOGIST
general/rawssrrep/jb
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Appendix 1.5 - Referrals to the general hospital during 1997
Department No. of Referrals in 1997 Group
(l)General Medicine 31 H/R
(2)General Surgery 12 H/R
(3)Haematology 12 H/R
(4)Anaesthetics 09 H/R
(5)Infectious Diseases 06 H/R
(6)Neurology 06 H/R
(7) Gynaecology 06 H/R
(8)Orthopaedics 01 O/N
(9)ENT 01 O/N
(lO)Urology 01 O/N
(ll)Dermatology 01 O/N
(12)Radiology 00 O/N
(13)Renal 00 O/N
(14)Cardiology 00 O/N
(15) Accident + Emergency 00 O/N
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Appendix 2.1 - Guidelines for submission to Sleep
SLEEP 
Information for Contributors 
SCOPE
O riginal m anuscripts, i.e ., th o se  that h ave  not been  
pu b lish ed  e lse w h e re  ex ce p t in  abstract form , on  any 
a sp ect o f  S le e p  (c lin ica l, experim ental, 
b io ch em ica l, e tc .) w il l  b e  con sid ered . Laboratory, 
c lin ica l, so c ia l, and h istor ica l n o tes  (no m ore than 
1 ,000  w ord s and tw o  fig u res), announcem ents o f  
m eetin g s  and aw ards, and b o o k  rev iew s are also  
pu blished.
ADDRESSES FOR CONTRIBUTIONS
Four c o p ies  o f  ea ch  su b m itted  m anuscript should be  
sent to  the E d itor-in -C h ief, Dr. Christian  
G uillem inaulL  I f  d esired , o n e  c o p y  m ay be sent to  
Dr. G u illem in au lt and three c o p ie s  sent to  an 
A sso c ia te  Editor, w h o  w ill th en  be respon sib le  for 
peer r ev iew  o f  the m a n u scr ip t Continental 
su b d iv isio n  (i.e . E urope and Latin A m erica; A sia  
and N orth  A m erica ) is recom m en d ed  for 
su b m issio n  to A sso c ia te  Editors. A ll 
com m u n ica tion  con cern in g  th e m anuscript should  
be d irected  to the E ditor-in -C hicf. C om m unication  
regarding accep tan ce o f  the m anuscript w ill com e  
from  the o ff ic e  o f  the E ditor-in-C hief.
Editor-in-Chief
Christian G u illem in au lt, M .D .
Stanford U n iv ersity  S leep  R esearch  Ctr.
701 W elch  R oad , Su ite  # 2 2 2 6  
P alo  A lto , C A  9 4 3 0 4  U S A  
F A X : (4 1 5 ) 7 2 5 -7 3 4 1
A s s o c ia te  E d ito r s:
T hom as R oth, P h .D . (C lin ical R esearch)
H enry Ford H osp ita l S leep  D isorders C enter  
29 2 1  W . Grand B lvd .
D etroit, M I 4 8 2 0 2  
F A X : (3 1 3 )8 7 4 -7 1 5 8
Jerom e SiegeL, Ph.D . (B asic  R esearch)
V A  M ed ica l C enter, N eu ro b io lo g y  R esearch (151 A 3 )
U C L A  D e p t  o f  P sych iatry
16111 Plum m er Street
Sep u lved a , C A  9 1 3 4 3
FA X : (8 1 8 ) 8 9 5 -9 5 7 5
M ich el B illiard . M .D . (C lin ica l R esearch)
N e u r o lo g ie  B , U n it 6 d es T roubles du  S om m eil
H opita l G ui de C bauliac
3 4 0 5 9  M ontp ellier  c ed ex
F R A N C E
3 3 -6 7 3 3 -6 7 7 0
R cidun U rsin , M .D . (B a sic  R esearch )
U niversitetet I B ergen  
F y s io lo g isk  Insritutt 
A rstad veicn  19 
N -5 0 0 9  B ergen  
N O R W A Y  
F A X : 4 7 -5 -2 0 6 -4 1 0
Sen d  all b o o k s  for rev iew  to D r. Christian  
G uillem inaulL
FORM OF MANUSCRIPTS
Subm it papers in  E nglish  w h en ever p ossib le . A rtic les  
in French w ill  a lso  b e  accep ted  and, w h en  published , 
w ill be accom p an ied  b y  a len gth y  E nglish  sum m ary. 
Four co p ie s  o f  each  m anuscript m ust b e  subm itted  in  
typew ritten form , d ou b le-sp aced  w ith a 5  cm  (2 -in ch ) - 
left m argin. T hree o f  the four cop ies m ay be  
ph otocop ies o f  th e original. P age 1 sh ou ld  b e a r  a) 
tide; b ) authors1 nam es; c) institution w here the w ork  
w as done, d) fo o tn o tes  to  th e tid e  or authors; e) a 
running tid e  o f  n o  m ore than 4 0  letters and sp aces; f) 
nam e, address, te lep h on e and fa x  num bers, and  
w h en ever  p o ss ib le , e -m ail address o f  the author to  
w h om  proofs sh ou ld  b e  s e n t  T o  facilitate the b lind  
rev iew  p ro cess , the authors' nam es sh ou ld  appear on ly  
on the first p age  o f  th e m an u scr ip t Prepare tab les o n  a 
separate sh eet, w ith  th e tid e  ab ove  and any description  
below .
Tables
T ables should  b e  as few  and sim p le  as possib le; 
they sh ou ld  n o t du plicate inform ation g iv en  in  
figures.
Figures
Figures sh ou ld  be subm itted  as clear, g lo s sy  prints  
(three du plicate co p ie s  m ay be p h otocop ies o f  the  
original art), p ro fessio n a lly  drawn and lettered, at least 
tw ice  th e final s iz e  and lettering large en ou gh  to be  
leg ib le  w h en  reduced. T he m axim um  final s iz e  o f  any 
figure in  the printed  journal w ill be 14 by 2 0  cm  (5  1/2 
by 8 inches). T he m axim um  s iz e  o f  artwork sen t  
should  b e  8 1/2 by 11 inches. Ordinate and ab sc issa  
sh ou ld  b e  labeled , calibration g iven , and sy m b o ls  and  
abbreviations exp la in ed  in  the legends. 
M icrophotographs m ay be subm itted in  final s iz e . A  
charge m ay be m ade for an ex cess iv e  num ber o f  
halftone plates. On th e back o f  each figure ind icate  the 
figure num ber and authors' nam es, and ind icate th e  top  
w ith  an arrow. A uthors are required to bear the c o st  o f  
reproducing figu res in color.
Text
T he text o f  the m anuscript should be in the fo llo w in g  
form: Sum m ary- T yp ed  o n  a separate sheet, the 
sum m ary sh ou ld  b e  150 to  20 0  w ords in  len gth  and  
su itab le for  u s e  b y  abstracting journals. State co n c ise ly  
and sp ec if ica lly  w h at w as done, w hat w as fou nd, and  
w hat con c lu sion s w ere reached. W henever p ossib le , 
supply  translation in French. A rticles subm itted  in  
French m ust be accom panied  by an E nglish  sum m ary. 
A pproxim ately  f iv e  k ey  w ords for u se  by abstracting  
serv ices sh ou ld  b e  p rov id ed  at the end o f  the  
•Sum m ary. Introduction: State the ob ject o f  research  
w ith  reference to p rev ious work. M ethods: D escr ib e  
m ethods in  su ffic ien t detail so  that th e work can  be  
duplicated, or c ite  p rev ious descriptions i f  th ey  are 
readily availab le. Inform ation m ust be inclu ded  
ind icating that c lin ica l experim ents conform  to  the  
D eclaration  o f  H elsin k i and anim al experim ents to  the  
p o licy  o f  the A m erican  P h ysio log ica l S o c ie ty . Editors 
w ill refu se  papers in w h ich  evidence o f  ad h eren ce to 
th ese  princip les is  n o t apparent. D ifferen ces o f  op in ion
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w ill be adjudicated b y  th e Editorial Board. R esults: 
D escribe the results c learly , co n c ise ly , and in  lo g ic a l  
order. W hen p o ssib le  g iv e  the range, standard  
d eviation , or m ean error and s ig n ifica n ce  o f  
d ifferences b etw een  num erical va lu es. D iscu ssio n :  
Interpret the results and relate them  to p revious w ork  
in the field. A ck n o w led g m en ts: T he minimum 
com patib le w ith  the requirem ents o f  cou rtesy  sh ou ld  
be typed on  a separate sheet. L egends: F igure leg en d s, 
num bered scq u en d a lly , are d ou b le-sp aced  on  a 
separate sheet. G iv e  th e m eanin g o f  all sy m b o ls  and  
abbreviations u sed  in th e figure.
R eferen ces
R eferences: T he journal com p lies  w ith the referen ce  
sty le  given  in "U niform  R equirem ents for  M anuscrip ts  
Subm itted to B io m ed ica l Journals" (see  A nn  Intern  
M ed 1979;90 :95 -9  or B r M ed J 1979;1 :532 -5 ). 
R eferences are to be c ited  in  the tex t by num ber and  
num bered in the order in  w hich  they are cited. T he  
reference section  sh ou ld  be typed d ou b le-sp aced  at the 
end o f  the tex t, fo llo w in g  the sam p le  form ats g iv en  
below . For abbreviations o f  journal nam es, refer  to  
L ist o f  Journals Indexed in Index M ed icu s (ava ilab le  
from the Superin tendent o f  D ocu m en ts, U .S . 
G overnm ent Printing O ff ic e , W ash ington , D .C . 2 0 4 0 2 ,  
U .S .A ., D H E W  P u blication  N o . (N IH ) 8 0 -2 6 7 ; IS S N  
0 0 9 3 -3 8 2 1 ). Provide all authors' nam es w hen  fe w er  
than seven; w hen  sev en  or m ore, lis t the first three and  
add et al. Provide article tit les  and in c lu siv e  pages. 
A ccu racy o f  referen ce data is  the resp on sib ility  o f  the  
author.
Sample References 
Article:
1.M eier-E w ert K , M atsubayashi K, B enter L. 
Propranolol: long-term  treatm ent in narcolepsv- 
cataplexy. S leep  1 9 8 5 ;8 :95 -104 .
2.Carskadon M A , D em en t W C. S leep  lo ss in e ld er ly  
volunteers. S leep  1985;8 :207 -21 .
B ook:
3 .G uillem inault C, Lugaresi E, eds. S leep /w ak e  
disorders: natural history , ep id em io lo g y , and long-term  
evolution. N e w  York: R aven  Press, 1983.
C h a p ter  o f  a  b ook :
4 .C olem an R M , B liw ise  D L, S a jb e n N , et al. 
E pidem io logy  o f  periodic m ovem ents during s leep . In: 
G uillem inault C, L ugaresi E, eds. S leep /w ak e  
disorders: natural h istory , ep id em io lo g y , and long-term  
evolution. N e w  York: R aven Press, 1 9 8 3 .2 1 7 -3 0 .
D eta ils  o f  S ty le
Drug nam es: U se  generic nam es in  referring to  drugs; 
trade nam es m ay be g iv en  in parentheses after th e first  
m ention, but the generic nam e sh ou ld  b e  u sed  
thereafter. A bbreviations: F o llo w  the lis t  o f  
abbreviations g iven  in  "U niform  R equirem ents for 
M anuscripts Subm itted to B iom ed ica l Journals" (se e  
section  on R eferen ces). For additional abbreviations, 
consult the C ou n cil o f  B io lo g y  Editors Style M anual 
(available from  the C ou n cil o f  B io lo g y  E ditors, Inc.,
9 6 5 0  R o ck v ille  P ik e , B ethesd a , M D  2 0 8 1 4 , U .S .A .)  or  
other standard sou rces.
SHORT NOTES AND LETTERS
Short notes m ay  b e  a m axim um  o f  6  d o u b le -sp aced , 
type-w ritten  p ages. O ne figu re or o n e  tab le m ay b e  
added, and the b ib liography m ay  h ave  a m axim u m  o f  
10 references. L etters, w hich  m ay  in c lu d e  interesting  
case  reports, sh ou ld  b e  11/2 d ou b le-sp aced  typew ritten  
pages at m ost. A  m ax im u m  o f  5 bib liographical 
references is r eco m m en d ed
FAST PUBLICATIONS
Short presentations (1 ,0 0 0  w ords or le ss )  m ay b e  
g iven  accelerated  rev iew s up on  request and approval 
by the Editorial B o a rd  The F ast P u blication  sec tio n  
w as created  fo r  presentations o f  s ign ifican t ad van ces  
in the fie ld . R e v ie w s  w ill b e  co m p le ted  w ith  the 
shortest p o ss ib le  d e lay , and reports w ill be in print 
w ith in  on e  or tw o  issu es  after rece ip t o f  the 
m anuscript.
REVIEWS
R e v iew s  are in v ited  b y  the E ditorial B o a rd  The 
R ev iew  sec tio n  m a y  also  inclu de sum m aries o f  
sym p osia  presentations at national or international 
m eetings. T h ese  invited  su b m iss ion s are rev iew ed  by  
Editorial Board m em bers. A d d ition s and ch an ges m ay  
be req uested  o f  th e author to  better com m u nicate  the 
stale o f  the art presented  in th e review .
ANNOUNCEMENTS
A nnou ncem en ts o f  con gresses , m eetin g s , courses, 
awards, and oth er item s lik ely  to be o f  interest to  the 
readers o f  S leep  m ay be subm itted to the o ff ic e  o f  the 
E ditor-in-C hief. P lease  g iv e  the nam e and address 
w here further inform ation  can be o b ta in ed
PROOFS AND REPRINTS
Proofs m u st be returned to the M anaging Editor at 
A llen  Press w ith in  5 days o f  receip t. Late return o f  
proofs m ay cau se  pu blication  o f  the article to be  
d e la y e d  P lease  ch eck  text, tab les, legen d s, and  
references carefu lly . It may be n ecessary  to  charge for 
alterations other than correction o f  printing errors. A n  
order form  for reprints w ill b e  inclu ded w ith  p roofs  
and m ust a lso  b e  returned to A lle n  Press. P roofs and 
reprint order form s should  b e  sen t to G ail M cN ich o la s , 
A llen  Press, Inc., 8 1 0  E. IOth S t., L aw rence, K S  
6 6 0 4 4 .
COPYRIGHT
C opyright on  all articles published in S leep  w ill be  
held b y  the A m erican  S leep  D isorders A sso c ia tio n  and  
the S leep  R esearch Society . In v ie w  o f  the present 
U .S . copyright law , it is necessary  that o n e  coauth or o f  
a subm itted m anuscript sign  a statem ent exp ress ly  
transferring cop yrigh t in the e ven t the paper is  
published in the journal. A  copyright transfer form  
w ill b e  sen t to  the corresp ondin g author b y  the o ff ic e  
o f  the E d itor -in -C h ie f w hen the receip t o f  a 
m anuscript is  ack n ow led ged .
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Appendix 3.1 - The multi-dimensinal health locus of control scale
This is a questionnaire d esign ed  to determ ine the way in which different p eo p le  view  certain important 
heaith-reiated is su e s . Each item is a belief statem ent with which you m ay a g r ee  or d isagree . B eside each  
sta tem en t is a  sca le  which ranges from strongly d isagree  (1) to strongly ag ree  (6). For ea ch  item w e would 
like you to circle the number that represents the extent to which you d isa g ree  or a g ree  with the statem ent. 
The m ore strongly you agree  with a statem ent, then the higher will be the num ber you circle. The more 
strongly you d isagree  with a statem ent, then the lower will be the num ber you circle. P le a s e  m ake sure that 
you answ er every item and that you circle o n ly  o n e  number per item. This is a  m ea su re  of your personal 
beliefs: obviously, there are no right or wrong answ ers.
P 'ea se  answ er th ese  item s carefully, but do not sp en d  too much time on any o n e  item. As much as you 
can, try to respond to each  item inaependently. W hen making your ch o ice , do not b e  influenced by your 
previous ch o ice s . It is important that you respond according to your actual beliefs and not according to how  
you feel you snouid believe or how you think w e want you to believe.
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1. If I get sick, it is my own behaviour which determ ines how
soon  I get well again. 1 2 3 4 5 6
2. No matter what I do. if I am going to get sick. I wiil get sick. 1 2 3 4 5 6
3 . Having regular contact with my doctor is the best way for m e
to avoid illness. 1 2 3 4 5 6
d . Most things that affect my health happen to me by accident. 1 2 3 4 5 6
5 . W henever I don't feel well. I should consult a  meaically
trained professional. 1 2 3 4 5 6
6. I am in control of my heaith. 1 2 3 4 5 6
7 . My family has a lot to do with my becom ing sick or staying
healthy. 1 2 3 d 5 6
8. W hen I get sick, I am to blame. 1 2 3 4 5 6
g_ Luck plays a  big pan in determining how soon I wiil recover
from an illness. 1 2 3 4 5 6
10. Health professionals control my health. 1 2 3 4 5 6
11. My good health is largely a matter of good fonune. 1 2 3 4 5 6
12 . The main thing which affects my heaith is what I myself do. 1 2 3 d 5 6
13. If I take care of myself. I can avoid illness. 1 2 3 4 5 6
14. W hen I recover from an iilness. it's usually b ecau se  other 
people (for example, doctors, nurses, family, friends) have
been  taking good care of me. 1 2 3 4 5 6
15. No matter what I do, I'm likely to get sick. 1 2 3 4 5 6
16. If it's m eant to be. I will stay healthy. 2 3 4 5 6
17. If I take the right actions. I can stay healthy. 1 2 3 4 5 6
18. Regarding my health, I can only do wnat my aoctor tells me
to do. 1 2 3 4 5 6
Appendix 3.2 - The health value scale
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Indicate the extent to which you agree with the following four statements, using 
the scale below. Write the appropriate number in the blank space to the right of each 
statement.
Strongly Moderately Moderately Strongly
agree agree disagree disagree
1 2 3 4 5 6 7
1) There is nothing more important than good heaith.
2) Good health is only of minor importance in a happy life.
3) If you don’t have your health, you don't have anything.
4) There are many things I care about more than my health.
Appendix 3.3 - The generalised self-efficacy scale
110
Not at all Barely Moderately Exactly
true true true true
1. I can always manage to solve difficult 
problems if I try hard enough. 1 2 3 4
2. If someone opposes me, I can find means 
and ways to get what I want. 1 2 3 4
3. It is easy for me to stick to my aims and 
accomplish my goals. 1 2 3 4
4. I am confident that I could deal efficiently with 
unexpected events. 1 2 3 4
5. Thanks to my resourcefulness, I know how to 
handle unforeseen situations. 1 2 3 4
6. I can solve most problems if I invest the 
necessary effort. 1 2 3 4
7. I can remain calm when facing difficulties 
because I can rely on my coping abilities. 1 2 3 4
8. When I am confronted with a problem, I 
can usually find several solutions. 1 2 3 4
9. If I am in a bind, I can usually think of 
something to do. 1 2 3 4
10. No matter what comes my way, I’m usually 
able to handle it. 1 2 3 4
I l l
Appendix 3.4 - Lothian Region Ethics Committee clearance
L O T H Ihealth
OU R R E F l LREC/1999/4
PLEASE Q UO TE IN ALL C O R R E SPO N D E N C E
2 M arch 1999
Professor Neil Douglas
R espiratory Medicine U nit  —
D epartm ent of Medicine 
Royal In firm ary  of Edinburgh 
L auriston  Place 
E dinburgh
D ear Professor Douglas,
R equest for E th ical Approval LREC/1999/4 -  CPAP C om pliance.
T hank you for your le tte r of 4 February 1999 asking if the use of 
psychological profiling using s tandard  questionnaires requires a full 
ethical submission or not. The C hairm an of the Medicine and Clinical 
Oncology Research Ethics Sub-Committee agrees th a t the use of a 
questionnaire as p art of the clinical process of identification of which 
pa tien ts  are more likely to use CPAP can be viewed as an  extension of 
clinical practice. Even if the results are audited  and  published, the 
C hairm an does not believe th a t this requires form al perm ission from the 
Sub-Com m ittee.
Yours sincerely
Val S tew art 
Secretary
Medicine and Clinical Oncology 
Research Ethics Sub-Committee
LOTH IAN H EA LT H  B O A R D
LOTHIAN RESEARCH ETHICS COMMITTEE
DEACONESS HOUSE
148 PLEASANCE EDINBURGH EH8 9RS
TE LE PHON E 0131 536 9000 DIRECT d i a l  0131 536 9028 f a c s i m i l e  0 1 3 1 5 3 6  9346
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Appendix 4.1 - Guidelines for submission to American Journal o f Respiratory and 
Critical Care Medicine
AJRCCM
INSTRUCTIONS FO R  CONTRIBUTORS
The AMERICAN JOURNAL OF RESPIRATORY AND 
CRITICAL CARE MEDICINE publishes original papers on 
laboratory and clinical research and clinical observations ihnt 
are pertinent to respiratory biology and medicine and critical 
care. Only papers written in English can be considered. The 
JOURNAL is published in both print and electronic formats 
and may be viewed online at http://www.atsj oumais.org or at 
http://intl.atsjournals.org from m a n y  countries in  Europe arxi 
Asia
SUBMISSION OF M ANUSCRIPTS
Send four copies o f the manuscript, four photocopies of line 
drawings and graphs, and four photographic prints o f each 
halftone to:
American Journal o f Respiratory and Critical Care Medicine
Editorial Office
211 West Wacker Drive
Suite 1000
Chicago, IL 60606
Authors are advised to keep one copy o f the complete 
manuscript on file, as no manuscripts or photographs will be 
returned. The JOURNAL is not responsible for manuscripts 
lost or damaged. Four photographic prints o f all illustrations 
will be required upon submission o f  revised manuscripts. One 
copy o f the manuscript and one copy o f  the photographic prints 
will remain on file in the editorial office. Reviewers are 
instructed to destroy the manuscript after review. Manuscripts 
that do not conform to guidelines may be returned to the 
author.
Manuscripts are acknowledged upon receipt. When inquiring 
about a manuscript, refer to the number assigned the 
manuscript.
Manuscripts judged by the Editors to be more appropriate for 
consideration by the American Journal o f Respiratory Cell and 
Molecular Biology will be transferred to that editorial office 
for review and potential publication. Authors will be notified 
of the transfer.
Be certain to list the FAX number of the corresponding author 
on the title page. All correspondence will be by FAX only. 
HANDLING OF M ANUSCRIPTS 
Manuscripts are accepted for publication on the basis of 
scientific merit, significance, and suitability for publication in a 
journal devoted to clinical and laboratory studies of respiratory 
and critical care medicine.
Oue set of paged galley proofs is provided before publication 
of each paper and must be returned within 48 hours o f receipt 
Alterations are to be kept to a minimum and may be made only 
on the paged gaQey proof. Please note that changes o f content 
and insertions of missing information will be billed to the 
author. An offprint order form is enclosed with the paged 
galleys.
On publication, each report indicates the dates that the original 
manuscript and the revised manuscript (if necessary) were 
received at the editorial office.
COVER LETT ER
A cover letter, signed by all the authors, listing the name, 
address, FAX, and telephone number (also E-mail address if 
available) of the corresponding author must accompany the 
manuscript The cover letter must also state that no part o f the 
research presented has been funded by tobacco industry 
sources. If any data are derived from subjects or animals of a 
previous report, this must be stated explicitly in the cover 
letter. This requirement applies even if  the data derived from 
these experiments do not overlap.
The authorf s) must state in this letter that the submitted 
material has not been published and is not being considered for 
publication elsewhere. Submission o f a manuscript indicates 
tacit acknowledgment that all authors have made significant 
contributions to the study and have read and approved the 
manuscript. Any change in authorship following the original 
submission must be justified and agreed to in writing by the 
affected authors).
In addition, an Assignment o f  Copyright form, signed by all 
authors, should accompany the manuscript This form may be 
obtained from the ATS website ctr from the Journal Editorial 
Office. The form may be photocopied.
The AMERICAN JOURNAL OF*RESPIRATORY AND 
CRITICAL CARE MEDICINE requires that any direct 
commercial association that might lead to a conflict o f interest 
must be disclosed by the authors) in the covering letter o f  
submission. This information will be withheld from the 
reviewers and will not affect acceptance for publication. Al the 
time o f publication, the information will be in a
footnote to the published manuscript 1 direct associations, 
such as consultancies, stock ownerships in an author's or 
relative's name, patents, etc., should be d isclovd in the letter to 
the Editor. The extent and means o f  possible disclosure will be 
determined by discussion with the Editor following acceptance 
o f the manuscript for publication.
P R IO R  PU BLICA TIO N
The journal does not publish original contributions that contain 
a significant portion of material that has been published or 
submitted for publication elsewhere, except for abstracts o f not 
more than 400 words. A computer search will be conducted to 
ensure that submissions have not been previously published. 
The Editors o f the JOURNAL reserve the right to determine 
what constitutes significant duplicate publication. If any 
material contained in the submitted manuscript has been 
published or submitted for publication elsewhere, the authotfs) 
must include four copies o f  a reprint or preprint containing this 
material at the time of submission.
Editorials and special features clearly designated as reviews 
may contain previously published material as long as it is 
appropriately referenced. It is the responsibility o f  the authors) 
to submit appropriate written permission to utilize previously 
published material that would otherwise violate copyright 
regulations.
HUMAN AND ANIM AL STUDIES
The AMERICAN JOURNAL OF RESPIRATORY AND 
CRITICAL CARE MEDICINE endorses the recommendations 
concerning human research that are contained in the 
Declaration o f Helsinki. The Editors reserve the right to reject 
any manuscript containing studies that do not conform to these 
recommendations. All manuscripts reporting human research 
must contain a statement in the text that the protocols were 
approved by the institutional review board for human studies 
and that informed written consent was obtained from the 
subjects or their surrogates if  required by the institutional 
review board.
Animal studies must conform to NIH guidelines (Guide for the 
Care and Use of Laboratory Animals, NTH Publication No. 86- 
23, Revised 1985, U.S. Government Printing Office, 
Washington, D.C. 20402-9325). Descriptions o f surgical 
procedures on animals should include the name, dose, and 
route of administration o f the anesthetic agent. Paralyzing 
agents are not an acceptable alternative to anesthesia and 
should be used only in conjunction with suitable anesthetic 
agents.
M ANUSCRIPTS
Manuscripts should be typed in 12-point type on white bond 
paper21.6 by 27.9 cm (8 1/2 x  11 in) with margins of at least 
2.5 Zm ( I in). Double spacing should be used throughout. A ll 
paDers should be organized to include: title page, abstract, text, 
acknowledgments, references, figure legends, footnotes, tables, 
and figures Each o f these elements shouid begin on a separate 
page. Pages should be numbered consecutively, beginning with 
the abstract 
Title Page
Tides should be limited to 85 characters. List (1) the title; (2) 
the first name, middle In itia l, and last name o f each author, (3) 
the name of department/s) and institution(s) to which the work 
should be attributed; (4) the name and address o f the author to 
whom requests for reprints should be addressed if  other than 
the senior author or the department o f origin; (5) corresponding 
author's FAX and phone numbers; (6) all source(s) o f support 
in the form of grants, gifts, equipment, and/or drugs; and (7) a
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short running head of no more than 35 characters (count letters 
and spaces).
A bstract
The second page should carry an abstract of not more than 200 
words, written as a single paragraph. It should be written for 
the readership o f both clinicians and basic investigators and 
should state the hypothesis or central question o f the study or 
investigation, the study subjects or experimental a n im a ls, 
ooservationaJ and analytical methods, the m ain  findings, and a 
final statement of the principal conclusions. Use only approved 
abbreviations.
Text
The text of articles 3hould usually, but not necessarily, be 
divided into the following sections: Introduction, Methods, 
Results, and Discussion. Long articles may require 
subheadings within some sections to clarify the contents, 
especially the Results and Discussion sections. There should 
not be more than two levels o f subheadings.
Manuscripts should be concise. Excessive length will reduce 
the likelihood of acceptance of the manuscript for publication. 
The introduction should have a clear statement o f the 
hypothesis or central question, any background material and 
supporting evidence, with an explanation o f the experimental 
approach.
Statements referring to work in progress or in prospect that 
imply future publication, in the JOURNAL or elsewhere, 
should not be used. Unpublished work should not be cited in 
References, but may be cited fully parenthetically within the 
text. Written permission from the author for citation of 
unpublished work should accompany the manuscript.
All cases of tuberculosis and all designators o f mycobacteria 
should be classified according to the 1990 edition of 
Diagnostic Standards and Classification o f Tuberculosis, 
published by the American Lung Association 
Generic names of drug3 should be used instead o f trade names. 
The location (city, state, country) o f a manufacturer listed in 
the text should be provided after the first reference to the 
manufacturer.
A laboratory or chemical term or a disease process may be 
abbreviated only after it has been written in fall at least once 
with the abbreviation in parentheses immediately after it, as in 
interstitial lung disease (ILD). Some common terms may 
alwavs be abbreviated such as P02, PC02, N2, CO, PaC02, 
PVC02, Sa02, AaP02, DLCO, FVC, FEV1, etc. Other terms 
should be defined the first time the term is used. Abbreviations 
should not begin a sentence. Specialized jargon should be 
avoided.
Units of measurement should conform to current scientific 
usage and can be abbreviated when they follow a number (e.g., 
cm, nm, ml, g, mg, nmol, °C) bui not otherwise. Unusual units 
should be defined
Statistical methods must be described. The standard error of 
the mean (+ SEM) must be distinguished from the standard 
deviation (± SD).
Acknowledgments
All acknowledgments should be grouped into one paragraph 
and placed after the Discussion.
References
References should be limited to 35 entries, typed double 
spaced, should begin on a separate sheet, and be numbered in 
the order that they appear in the text. All author's names (do 
not use "et al"), complete article titles, and articles in press 
should be included Supply inclusive page numbers. Submitted 
manuscripts which have not been accepted for publication are 
considered as unpublished work and should not be included in 
the references. If an article cited in References is in press, four 
copies of that article should be included with the submitted 
manuscript.
Use abbreviations for the names o f all journals as provided in 
Index Medicus. Spell out the names of journals that are not 
listed
A reference for the statistical methods used should be cited 
Examples of References 
Journal Articles
Jones, D.A., S. HoweO, C. Roussos, and R. H. T. Edwards.
1982. Low-frequency fatigue in isolated skeletal muscles and 
the effects o f  methybcanthines. Clin. Sci. 63:161-167.
In Press
Lakatos, E., D. L. DeMets, W. B. Kannel, P. Soriie, p. 
MacNamara. 1994. Influence o f  cigarette «moln-no on lung 
function and COPD incidence. The Framingham study. J. 
Chronic Dis.
Abstracts
Louis, M., J.B. Thorens, and J.C. Chevrolet. 1993. Calcium- 
diannel blockers testing for primary pulmonary hypertension 
associated with HTV infection (abstract). Am Rev. Respir. Dis. 
147-A536.
Books
Snedecor, G.W., and W.G. Cochran. 1967. Statistical Methods, 
6 th e d  Iowa State University Press, Ames. 258-296.
Articles in Books
Rail, T. W. 1980. Central nervous system stimulants 
(continued): the xanthines. In A. G. Gilman, L. S. Goodman, 
and A. Gilman, editors. The Pharmacological Basis of 
Therapeutics, 6 th e d  Macmillan, New York. 595-607. 
Governm ent o r  Association Report 
U.S. Public Health Service: 1979. Smoking and Health. A 
Report on the Surgeon GeneraL U.S. Government Printing 
Office, W a s h in g t o n , DC. DHEW Publication No. (PHS)79- 
50066.
Tables
Tables should be configured to fit vertically on the printed 
page. They will be typeset to fit a width o f 314 inches (9 
centimeters) for single column or up to 7V4 inches (18/3 
centimeters) for double c o lu m n . Tables that do not fit into this 
format will be returned for reworking.
Each table should be typed double spaced on a separate sheet. 
Do not submit tables as photographs. Tables should be 
□umbered consecutively, have a brief title, and be cited in texL 
Avoid arbitrary labels or classifications, such as groups A and 
B, when specific descriptors, such as "control" and "hypoxia" 
can be used
All non-standard abbreviations used in each table should be 
explained in footnotes. For footnotes, use the following 
symbols in this sequence: ” , dagger, double dagger, §, U, ” , 
two dagger, etc.
Illustrations
Four photocopies o f line drawings and graphs, and four 
photographic prints of each halftone should be submitted with 
the manuscript Four photographic prints o f all illustrations, 
will be required upon submission o f revised manuscripts. 
Illustrations must be good quality, unmounted prints, sized so 
they can be reduced to a width of j '/i inches (9 centimeters) for 
single column, and not exceeding 7V» inches (18'/j centimeters) 
for double c o lu m n  Halftones must be on glossy paper. Line 
drawines need not be on glossy paper, however, they may not 
be photocopies. The size o f the symbols and lettering should be 
in scale with the figure. All figures within an article should be 
the same point size. Multipart figures should be submitted as 
single composites, with each panel labeled (e.g.. A, 3). Labels 
indicating subparts of a figure (A, B, C, etc.) should be 
boldface and capitalized but should not be larger than the type 
used in the text o f the published article (i.e., after the figure is 
reduced to fit the width o f one column the labels and text in the 
figure should not be larger than 10 points (3-4 mm in height]). 
To further save space, all figure titles and explanations of 
symbols should appear only in the figure legend, not in the 
actual figure. Labels should be placed within the body o f the 
figure, not outside i t  The abscissa and ordinate of each graph 
should be labeled clearly. Computer-generated graphics are 
acceptable, as long as they provide adequate reproducibility, 
we reserve the right to request glossy prints and to return 
unacceptable configurations for additional cropping and/or 
vertical orientation at the author's expense. Color prints are 
preferred to transparencies.
COLOR
The cost o f publishing color art in the JOURNAL is partially 
subsidized by the ATS with a portion of the costs billed to 
authors according to the following prices: S650 for the first
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color page and 5400 for each additional page that contains 
color. Lead authors with manuscripts accepted for publication 
will be asked to confirm in writing their acceptance and 
responsibility for payment of this color art billing. I f  the color 
quote is not accepted, the author must indicate whether the 
figure should be printed in black and white or deleted. Color 
prints are preferred to transparencies.
Legends for Illustrations
Legends for illustrations should convey the findings and be 
typed double spaced, start on a separate page with arabic 
numerals corresponding to the illustrations. When symbols, 
arrows, numbers, or letters ore used to identify parts o f the 
illustrations, each one should be identified and explained 
clearly in the legend
In photomicrographs, explain internal scale and identify the 
method of staining.
Each figure should be cited in numerical order in the text 
Subm itting Figures on Disk 
Figures may now be submitted as digital files on disk 
However, because o f the great variety of graphics software and 
formats available, the digital art file may not be usable. For this 
reason, as well as to provide a double check of the proper 
image, authors must include a high quality 'hard  copy' 
produced from the digital files. The Journal reserves the right 
at any time to use this hard copy as camera copy rather than 
using the digital file. Digital figures must be submitted as TIFF 
or EPS tiler, color art may only be submitted in the CMYK 
format. Fonts in EPS files should be converted to "create 
outlines" or "convert to paths," as this will eliminate the need 
to download the fonts for outputting. Black and white line art 
must be processed at a minimum o f 900 dpi (data per inch), 
halftones at 300 dpi, combos (color image + type, or black and 
white image + type) at 500 dpi, and color at 300 dpi. Images 
and text should be submitted on separate disks.
Please download the Guidelines for Submitting Digital Image 
Files from the ATS website or call the Journal Editorial Office 
for detailed information on resolution, file format, and other 
important details about digital art submission.
CASE REPORTS
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Appendix 4.2 - Subject consent form
Research Study
We are currently undertaking a study in the department which aims to evaluate 
some of the beliefs held by CPAP users about their health and health related behaviours. 
It is hoped that information gained from this study will help to improve the service 
offered to patients who attend the department.
If you agree to take part you will be asked to complete three questionnaires 
which will take no longer than ten minutes to complete. Your responses will be stored 
for later analysis, but this process is completely confidential and will in no way affect 
your treatment in the department.
You are under no obligation to take part in the study and if you consent you can 
withdraw at any time. Refusal or withdrawal of consent will not affect your treatment in 
this department.
Thank you for your time.
I ...................................................................................(name in block capitals) agree to take
part in the above study. I understand that the information gained from me will be treated 
with complete confidentiality and will not affect my treatment.
Signed (patient)...........................................................
D ate...............................
Signed (staff member)...............................................................
D ate...............................
